CONDENSED RING DERIVATIVE, AND PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF

Abstract

Disclosed are a condensed ring derivative, and a preparation method, an intermediate, a pharmaceutical composition and a use thereof. The condensed ring derivative of the present invention has a significant inhibitive effect on URAT1, which can effectively alleviate or treat hyperuricemia and other related diseases.

Claims

1. A condensed ring derivative having a structure of formula II, a tautomer, a mesomer, a racemate, an enantiomer, a diastereoisomer, or a pharmaceutically acceptable salt, a metabolite, a metabolic precursor or a pro-drug thereof, ##STR00150## M is H, D or a pharmaceutically acceptable cation; U is ##STR00151## X.sup.1 is CH or N, Y is ##STR00152## or N; each of R.sup.1 and R.sup.2 is independently H, D, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl or a heterocycloalkyl; or, R.sup.1, R.sup.2 together with the carbon atom attached form a cycloalkyl or a heterocyclic group; the alkyl, the alkoxy, the cycloalkyl, the alkenyl, the alkynyl, the heterocycloalkyl, the cycloalkyl formed by R.sup.1, R.sup.2 and the carbon atom attached, or the heteroalkyl formed by R.sup.1, R.sup.2 and the carbon atom attached can further be substituted by a substituent selected from the group consisting of D, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl, a heterocycloalkyl or an aryl; R.sup.3 is H, D, a halogen, an alkyl, an alkoxy, an aryl, a heteroaryl, a heterocycloalkyl or an amino; wherein the alkyl, the alkoxy, the aryl, the heteroaryl, the heterocycloalkyl or the amino can be further substituted by a substituent selected from the group consisting of D, a halogen, CN, an alkyl, an aryl, an aryl substituted by halogen, a benzyl, a benzyl which is substituted by halogen in the phenyl, a benzoyl or a benzoyl which is substituted by halogen in the phenyl; when the substituents are more than one, the substituents are the same or different; R.sup.4 is D, CN, NH.sub.2, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl, a heterocycloalkyl, an aryl or a heteroaryl; wherein NH.sub.2, the cycloalkyl, the alkenyl, the alkynyl, the heterocyclic group, the aryl or the heteroaryl can further be substituted by a substituent selected from the group consisting of D, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl, a heterocycloalkyl, an aryl, an aryl substituted by a halogen and/or CN, a heteroaryl or a heteroaryl substituted by CN; the alkyl or the alkoxy is substituted by a substituent selected from the group consisting of D, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl, a heterocycloalkyl, an aryl, an aryl substituted by a halogen and/or CN, a heteroaryl or a heteroaryl substituted by CN; each of R.sup.5 and R.sup.6 is independently H, D, OH, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl or a heterocycloalkyl; or R.sup.5, R.sup.6 together with the carbon atom attached form a cycloalkyl or a heterocyclic group; the alkyl, the alkoxy, the cycloalkyl, the alkenyl, the alkynyl, the heterocycloalkyl, the cycloalkyl formed by R.sup.5, R.sup.6 together with the carbon atom attached or the heterocyclic group formed by R.sup.5, R.sup.6 together with the carbon atom attached can further be substituted by a substituent selected from the group consisting of D, a halogen, CN, an alkyl, an alkoxy, a cycloalkyl, an alkenyl, an alkynyl, a heterocycloalkyl or an aryl; n is 0, 1 or 2; and p is 1, 2, or 3 .

2. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1, wherein, M is H or a pharmaceutically acceptable cation; each of R.sup.1 and R.sup.2 is independently H, D or an alkyl; or R.sup.1 and R.sup.2, together with the carbon atom attached form a cycloalkyl; R.sup.3 is H, a halogen, an alkyl or an aryl; R.sup.4 is H, a halogen, an alkyl, an aryl or a heteroaryl; each of R.sup.5 and R.sup.6 is independently H, OH, a halogen or an alkyl; and p is 1.

3. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1, wherein, M is N.sub.2 ion, K ion or Ca ion; or, each of R.sup.1 and R.sup.2 is independently F, Cl, Br or I, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.3-6 cycloalkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, or a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O, S or N; or, R.sup.1 and R.sup.2 together with the carbon atom attached form a C.sub.3-6 cycloalkyl; or, R.sup.1 and R.sup.2 together with the carbon atom attached form a C.sub.2-5 heterocyclic group having 1-2 heteroatom(s) selected from O or S; or, R.sup.3 is F, Cl, Br or I, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.6-10 aryl, or a C.sub.2-5 heteroaryl having 1-3 heteroatom(s) selected from N, or a C.sub.2-10 heterocycloalkyl having 1-3 heteroatom(s) selected from N, O or S; or, R.sup.4 is F, Cl, Br or I, a C.sub.1-4 alkyl, a C.sub.1-4 alkoxy, a C.sub.3-6 cycloalkyl, a C.sub.2-4 alkenyl, a C.sub.2-4 alkynyl, or a C.sub.2-10 heterocycloalkyl having 1-3 heteroatom(s) selected from N, O or S, or a C.sub.6-10 aryl, or a C.sub.2-10 heteroaryl having 1-2 heteroatom(s) selected from O; or, each of R.sup.5 and R.sup.6 is independently F, Cl, Br or I, a C.sub.1-4 alkyl, C.sub.1-4 alkoxy, a C.sub.3-6 cycloalkyl, a C.sub.2-4 alkenyl, a C.sub.2-4 alkynyl, or a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O, S or N, or R.sup.5 and R.sup.6 together with the carbon atom form a C.sub.3-6 cycloalkyl, or R.sup.5, R.sup.6 together with the carbon atom attached form a a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O or S.

4. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1, wherein, the cycloalkyl formed by R.sup.1 and R.sup.2 together with the carbon atom attached, the heterocyclic group formed by R.sup.1, R.sup.2 together with the carbon atom attached, is substituted by a substituent select from the group consisting of F, Cl, Br, I, a C.sub.1-4 alkyl, a C.sub.1-4 alkoxy, a C.sub.3-6 cycloalkyl, a C.sub.2-4 alkenyl, a C.sub.2-4 alkynyl, a C.sub.6-10 aryl, a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O, S or N; or, the cycloalkyl formed by R.sup.5, R.sup.6 together with the carbon atom attached or the heterocyclic group formed by R.sup.5, R.sup.6 together with the carbon atom attached is substituted by a substituent selected from the group consisting of F, Cl, Br, I, a C.sub.1-4 alkyl, a C.sub.1-4 alkoxy, a C.sub.3-6 cycloalkyl, a C.sub.2-4 alkenyl, a C.sub.2-4 alkynyl, a C.sub.6-10 aryl, a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O, S or N; or, the alkyl, the alkoxy, the aryl, the heteroaryl, the heterocycloalkyl or the amino defined in R.sup.3 is substituted by a substituent selected from the group consisting of F, Cl, Br, I, a C.sub.1-4 alkyl, a C.sub.6-10 aryl, 2,6-dichlorophenyl, 2,6-dichlorobenzyl and 2,6-dichlorobenzoyl; or, NH.sub.2, OH, the alkyl, the alkoxy, the cycloalkyl, the alkenyl, the alkynyl, the heterocycloalkyl, the aryl or the heteroaryl defined in R.sup.4 is substituted by a substituent selected from the group consisting of F, Cl, Br, I, a C.sub.1-4 alkyl, a C.sub.1-4 alkoxy, a C.sub.3-6 cycloalkyl, a C.sub.2-4 alkenyl, a C.sub.2-4 alkynyl, a C.sub.6-10 aryl, a C.sub.2-10 heterocycloalkyl having 1-2 heteroatom(s) selected from O, S or N, ##STR00153## and a C.sub.2-10 heteroaryl having 1-2 heteroatom(s) selected from O.

5. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 3, wherein, each of R.sup.1 and R.sup.2 is independently methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or tert-butyl; or, R.sup.1 and R.sup.2 together with the carbon atom attached form a cyclobutyl; or, R.sup.3 is methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, a phenyl, a pyridyl or ##STR00154## or, R.sup.4 is a phenyl, a naphthyl, ##STR00155## or, each of R.sup.5 and R.sup.6 is independently methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or tert-butyl.

6. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1, wherein, the compound having a structure of formula II has a structure of formula II-1: ##STR00156## in the formula II-1, the definitions of X.sup.1, Y, R.sup.1, R.sup.2, R.sup.4, U, M and n refer to those in claim 1.

7. The condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 6, wherein, in the compound of general formula II-1, each of R.sup.1 and R.sup.2 is independently H, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or tert-butyl; or R.sup.1, R.sup.2 together with the carbon atom attached form a cyclobutyl; M is H; R.sup.4 is a phenyl, a naphthyl, ##STR00157## U is ##STR00158## each of R.sup.5 and R.sup.6 is independently H, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl or tert-butyl; n is 1; or, in the compound of formula II-1, where U is ##STR00159## and R.sup.5 and R.sup.6 are H, R.sup.1 and R.sup.2 are not H at the same time.

8. A condensed ring derivative, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof, of the structures selected from ##STR00160## ##STR00161## ##STR00162## ##STR00163## ##STR00164## wherein in the above compounds, the carbon atom marked with * refers to a chiral carbon atom or a non-chiral carbon atom, when it is a chiral carbon atom, it is of S-configuration or R-configuration, when it is a non-chiral carbon atom, it refers to racemate.

9. The compound of formula II-a: ##STR00165## wherein M.sup.1 is an alkyl; in the compound of formula II-a, X.sup.1 is CH or N; Y is CH or Y; the definitions of R.sup.1, R.sup.2, R.sup.3, R.sup.4, U, n and p refers to those in claim 1.

10. The compound of formula II-a according to claim 9, wherein, the compound of formula II-a has a structure of formula II-a-1: ##STR00166## wherein, the definitions of R.sup.1, R.sup.2, R.sup.4, U, M.sup.1 and n refer to those in claim 9.

11. The compound of formula II-a according to claim 9, wherein, the compound is selected from the group consisting of ##STR00167## ##STR00168## ##STR00169## ##STR00170## ##STR00171## in the above compounds, the carbon atom marked with * is a chiral carbon atom or a non-chiral carbon atom, when it is a chiral carbon atom, it is of S-configuration or R-configuration, when it is a non-chiral carbon atom, it refers to racemate.

12-13. (canceled)

14. A pharmaceutical composition, comprising a pharmaceutically effective amount of the condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1, and one or more than one pharmaceutically acceptable carrier and/or diluent.

15. The pharmaceutical composition according to claim 14, wherein, the composition further contains other uric acid-lowering drugs; the uric acid-lowering drugs is selected from the group consisting of uric acid transporter 1 inhibitor, xanthine oxidase inhibitor, xanthine oxidoreductase and xanthine dehydrogenase inhibitor, or purine alcohol and/or Febuxostat.

16. A medicament for preventing and/or treating hyperuricemia, gout, hypertension, diabetes, hypertriglyceridemia, metabolic syndrome, coronary heart disease or kidney damage manufactured from the condensed ring derivative having a structure of formula II, the tautomer, the mesomer, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabolite, the metabolic precursor or the pro-drug thereof according to claim 1.

17. A method for treating hyperuricemia or the disease related to hyperuricemia comprising: administrating to the subject the condensed ring derivative having a structure of formula II, the tautomer, the mesomere, the racemate, the enantiomer, the diastereoisomer, or the pharmaceutically acceptable salt, the metabiolite, the metabolic precursor or the pro-drug thereof according to claim 1.

18. The method according to claim 17 wherein the disease related to hyperuricemia is selected from the group consisting of gout, hypertension, diabetes, hypertriglyceridemia, metabolic syndrome, coronary heart disease and kidney damage.

Description

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

[0118] The structure of the compound is determined by NMR or MS, NMR is obtained by Bruker Avance-500 apparatus, d.sub.6-DMSO, CDCl.sub.3 and CD.sub.3OD etc. as a solvent, TMS as an interior label. MS is obtained by LC-MS Agilent Technologies 6110, ESI as an ion source.

[0119] Microwave reaction is conducted in Explorer full automatic microwave irradiation equipment supplied by CEM, US Corporation, magnetron frequency is 2450 MHz, continuous microwave output power is 300 W.

[0120] HPLC is Gilson 281, the preparative column is Xbridge, 21.2?250 mm C18, 10 ?m.

[0121] Process I for separating enantiomers: the apparatus is Gilson 281, the preparative column is r,r-Whelk-O1 (20?250 mm, 5 ?m); process II: the apparatus is SFC-80 (Thar, Waters), the preparative column is AD 30?250 mm, 5 ?m (Decial).

Embodiment 1

4-(4-cyanophenyl)isoquinoline-6-carboxylic acid (Compound 1)

[0122] ##STR00091##

[0123] Synthesis of Compound 1-c

[0124] Under CO atmosphere (30 atm), 6-bromoisoquinoline (10.0 g, 48 mmol), sodium acetate (5.0 g, 61 mmol), triphenylphosphine (3.8 g, 14 mmol) and palladium acetate (2.8 g, 12 mmol) were dissolved in DMF (40 mL) and methanol (40 mL), the mixture was reacted at 100? C. for 24 hrs. The mixture was then cooled to room temperature, evaporated to remove methanol, the residue was filtered through celite, the filtrate cake was washed with EA (200 mL). The filtrate was washed in turn with water (100 mL?3) and saturated brine (100 mL), dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure. The residue was purified with silica column chromatography (PE: EA=10:1) to give white solid 1-c (7 g, yield: 78%). LC-MS (ESI): m/z=188 [M+H].sup.+

[0125] Synthesis of Compound 1-b

[0126] Compound 1-c (1.88 g, 10 mmol) and N-bromosuccinimide (2.7 g, 15 mmol) were dissolved in acetic acid (40 mL), the mixture was cooled to room temperature after reacting at 80? C. for 24 hrs. Part of acetic acid was removed under reduced pressure, the residue was filtered through celite, the filtrate cake was washed with DCM (200 mL). The filtrate was in turn washed with saturated sodium sulfite solution (200 mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=50:1) to give colorless solid 1-b (2.5 g, yield 94%). LC-MS (ESI): m/z=266 [M+H].sup.+.

[0127] Synthesis of Compound 1-a

[0128] Under N.sub.2 atmosphere, compound 1-b (133 mg, 0.5 mmol), 4-cyanophenylboronic acid (75 mg, 0.5 mmol) and sodium carbonate (60 mg, 0.6 mmol) were suspended in a mixed solution of dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (25 mg, 0.03 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, then cooled to room temperature. The mixture was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 1-a (126 mg, yield 83%). LC-MS (ESI): m/z=289 [M+H].sup.+.

[0129] Synthesis of Compound 1

[0130] At room temperature, LiOH (42 mg, 1.0 mmol) was added to a solution of compound 1-a (120 mg, 0.42 mmol) in a mixed solution of methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred at room temperature for 1 h, followed by adding 2M HCl aqueous solution (1 mL) and water (20 mL), solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 1 (91 mg, yield 79%). LC-MS (ESI): m/z=295 [M+H].sup.+.

[0131] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 13.55 (s, 1H), 9.53 (s, 1H), 8.60 (s, 1H), 8.34 (m, 2H), 8.21 (m, 1H), 8.10 (d, J=8.0 Hz, 1H), 7.82 (d, J=8.0 Hz, 1H) ppm.

Embodiment 2

3-[4-(4-Cyanophenyl)isoquinolin-6-yl]propionic acid (Compound 2)

[0132] ##STR00092##

[0133] Synthesis of Compound 2-d

[0134] A solution of compound 1-c (1.33 g, 5 mmol) in DCM (50 mL) was cooled to ?78? C., 1.0M diisobutylaluminum hydride in DCM (20 mL, 20 mmol) was slowly added dropwise, the mixture was further stirred for 1 h. The mixture was warmed to room temperature, saturated aqueous solution of NH.sub.4Cl (300 mL) was added, organic phase was seperated, aqueous phase was extracted with DCM (50 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=3:1) to give light yellow solid 2-d (900 mg, yield 76%). LC-MS (ESI): m/z=236 [M+H].sup.+.

[0135] Synthesis of Compound 2-c

[0136] At 0? C., triethyl phosphonoacetate (1.4 mL, 5 mmol) and sodium hydride (240 mg, 6 mmol) were added into a solution of compound 2-d (470 mg, 2 mmol) in THF (10 mL), the mixture was further stirred for 1 h. The mixture was warmed to room temperature, followed by adding saturated aqueous solution of NH4Cl (300 mL), extracted with EA (50 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=5:1) to give light yellow solid 2-c (380 mg, yield 62%). LC-MS (ESI): m/z=306 [M+H].sup.+.

[0137] Synthesis of Compound 2-b

[0138] At 0? C., NaBH.sub.4 (40 mg, 1 mmol) was added slowly into a solution of compound 2-c (310 mg, 1 mmol) and NiCl.sub.2 (13 mg, 0.1 mmol) in methanol (5 mL), the mixture was further stirred for 3 hrs. The mixture was warmed to room temperature, followed by adding saturated aqueous solution of NH.sub.4Cl (30 mL), being extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (5 mL?3) and saturated brine (5 mL), dried over anhydrous sodium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=4:1) to give light yellow solid 2-b (280 mg, yield 91%). LC-MS (ESI): m/z=308 [M+H].sup.+.

[0139] Synthesis of Compound 2-a

[0140] Under N.sub.2 atmosphere, compound 2-b (155 mg, 0.5 mmol), 4-cyanophenylboronic acid (75 mg, 0.5 mmol) and sodium carbonate (106 mg, 1 mmol) were suspended in a mixture of dioxane (4 mL) and water (1 mL), [1,1-bis (diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, then cooled to room temperature. The mixture was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=1:1) to give compound 2-a (100 mg, yield 61%). LC-MS (ESI): m/z=331 [M+H].sup.+.

[0141] Synthesis of Compound 2

[0142] At room temperature, LiOH (42 mg, 1.0 mmol) was added to a mixed solution of compound 2-a (100 mg, 0.3 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL), the mixture was further stirred for 1 h, 2M HCl aqueous solution (1 mL) and water (20 mL) were added, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 2 (61 mg, yield 67%). LC-MS (ESI): m/z=303 [M+H].sup.+.

[0143] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.18 (s, 1H), 9.34 (s, 1H), 8.44 (s, 1H), 8.18 (d, J=8.0 Hz, 1H), 8.04 (d, J=8.0 Hz, 2H), 7.77 (d, J=8.0 Hz, 2H), 7.68 (d, J=8.0 Hz, 1H), 2.99 (t, J=8.0 Hz, 2H), 2.59 (t, J=8.0 Hz, 1H) ppm.

Embodiment 3

2[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]acetic acid (Compound 3)

[0144] ##STR00093##

[0145] Synthesis of Compound 3-d

[0146] CuCN (5.0 g, 56.3 mmol) was added to a solution of 1,4-dibromonaphthalene (20 g, 70.4 mmol) in DMF (250 mL), the mixture was reacted for 16 hrs at 125? C., evaporated under reduced pressure. Aqueous ammonia (200 mL) and EA (200 mL) were added to the residue, the mixture was stirred for 1 h and organic phase was seperated. The organic phase was in turn washed with water (100 mL?3) and saturated brine (100 mL), dried over anhydrous magnesium sulfate, filtered, evaporated under reduced pressure. The residue was purified with silica chromatography (PE:EA=10:1) to give compound 3-d (5.1 g, yield 31%). LC-MS (ESI): m/z=232 [M+H].sup.+.

[0147] Synthesis of Compound 3-c

[0148] Under N.sub.2 atmosphere, bis(pinacolato)diboron (8.4 g, 33 mmol), potassium acetate (6.5 g, 66 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (1.2 g, 1.76 mmol) were respectively added to a solution of compound 3-d (5.1 g, 22 mmol) in dioxane (150 mL), the mixture was stirred at 80? C. for 6 hrs. The mixture was evaporated under reduced pressure, the residue was filtered through celite, the filtrate cake was washed with dioxane (50 mL), the filtrate was evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=10:1) to give compound 3-c (6 g, yield 97%). LC-MS (ESI): m/z=280 [M+H].sup.+.

[0149] Synthesis of Compound 3-b

[0150] At 0? C., under N.sub.2 atmosphere, potassium tert-butanolate (71 mg, 0.63 mmol) was added to a solution of methyl(methylthiomethyl)sulfoxide (78 mg, 0.63 mmol) in anhydrous THF (5 mL). The mixture was stirred for 30 mins, followed by adding compound 2-d (100 mg, 0.42 mmol), stirred for 1 h at room temperature, then evaporated under reduced pressure. 2M HCl in methanol (5 mL) was added to the residue, the mixture was refluxed for 3 hrs, then concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=5:1) to give compound 3-b (70 mg, yield 60%). LC-MS (ESI): m/z=281 [M+H].sup.+.

[0151] Synthesis of Compound 3-a

[0152] Under N.sub.2 atmosphere, compound 3-c (40 mg, 0.14 mmol), sodium carbonate (46 mg, 0.43 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (30 mg, 0.036 mmol) were respectively added to a mixed solution of compound 3-b (40 mg, 0.14 mmol) in ethylene glycol dimethyl ether (150 mL) and water (1 mL). The mixture was stirred at 75? C. for 16 hrs, and then concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 3-a (27 mg, yield 53%). LC-MS (ESI): m/z=353 [M+H].sup.+.

[0153] Synthesis of Compound 3

[0154] At room temperature, 1M LiOH aqueous solution (1.0 mL) was added to a mixed solution of compound 3-a (27 mg, 0.076 mmol) in methanol (5 mL) and THF (5 mL), the mixture was stirred for 16 hrs, and evaporated under reduced pressure. The residue was dissolved with water (6 mL), adjusted to pH=3 with 1M citric acid aqueous solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 3 (20 mg, yield 77%). LC-MS (ESI): m/z=339 [M+H].sup.+.

[0155] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.34 (s, br., 1H), 9.47 (s, 1H), 8.45 (s, 1H), 8.35 (d, J=8.0 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 8.24 (d, J=8.0 Hz, 1H), 7.85 (t, J=8.0 Hz, 1H), 7.73 (d, J=8.0 Hz, 2H), 7.64 (d, J=8.0 Hz, 1H), 7.59 (t, J=8.0 Hz, 1H), 7.41 (d, J=8.0 Hz, 1H), 7.14 (s, 1H), 3.63 (s, 2H) ppm.

Embodiment 4

2{[4-(4-Cyanophenyl)isoquinolin-6-yl]thio-2-methylpropionic acid (Compound 4)

[0156] ##STR00094##

[0157] Synthesis of Compound 4-c

[0158] 6-Bromoisoquinoline (10.4 g, 50 mmol) and N-iodosuccinimide (13.5 g, 60 mmol) were dissolved in acetic acid (100 mL), the mixture was reacted for 8 hrs at 80? C. The mixture was cooled to room temperature, followed by concentrating under reduced pressure to remove half of acetic acid, the residue was filtered through celite, the filtrate cake was washed with DCM (200 mL), the organic phase was in turn washed with saturated sodium sulfite solution (200 mL) and water (100 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=5:1) to give compound 4-c (11.6 g, yield 70%). LC-MS (ESI): m/z=334 [M+H].sup.+.

[0159] Synthesis of Compound 4-b

[0160] Under N.sub.2 atmosphere, compound 4-c (2.33 g, 10 mmol), 4-cyanobenzene boronic acid (1.5 g, 10 mmol) and sodium carbonate (2.12 g, 20 mmol) were suspended in dioxane (40 mL) and water (10 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (0.55 g, 1 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, and then cooled to room temperature. The mixture was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (100 mL?3) and saturated brine (100 mL), dried over magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 4-b (1.6 g, yield 52%). LC-MS (ESI): m/z=309 [M+H].sup.+.

[0161] Synthesis of Compound 4-a

[0162] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (0.29 g, 0.5 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (0.46 mg, 0.5 mmol) were added to a solution of compound 4-b (1.5 g, 5 mmol), ethyl 2-methyl-2-mercaptopropionate (0.75 g, 5 mmol) and diisopropylethylamine (1.29 g, 1 mmol) in dioxane (8 mL), the mixture was reacted in microwave at 110? C. for 30 mins. The mixture was cooled to room temperature, concentrated under reduced pressure to remove dioxane. The residue was filtered through celite, the filtrate cake was washed with EA (200 mL). The filtrate was in turn washed with water (100 mL?3) and saturated brine (100 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 4-a (1.39 g, yield 74%). LC-MS (ESI): m/z=377 [M+H].sup.+.

[0163] Synthesis of Compound 4

[0164] At room temperature, LiOH (0.178 g, 0.74 mmol) was added to a mixed solution of compound 4-a (1.39 g, 0.37 mmol) in methanol (5 mL), THF (20 mL) and water (5 mL), the mixture was stirred at room temperature for 1 h, 2M HCl aqueous solution (2 mL) and water (20 mL) were added, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 4 (1.1 g, yield 85%). LC-MS (ESI): m/z=349 [M+H].sup.+.

[0165] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.78 (s, 1H), 9.41 (s, 1H), 8.53 (s, 1H), 8.23 (d, J=8.0 Hz, 1H), 8.06 (d, J=8.0 Hz, 2H), 7.73 (m, 4H), 1.44 (s, 6H) ppm.

Embodiment 5

2{[4-(4-Cyanonaphthalen)isoquinolin-6-yl]thio}-2-methylpropionic acid (Compound 5)

[0166] ##STR00095##

[0167] Synthesis of Compound 5-b

[0168] Under N.sub.2 atmosphere, compound 4-c (0.66 g, 2 mmol), compound 3-c (0.56 g, 2 mmol) and sodium carbonate (0.42 g, 0.4 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (0.12 g, 0.2 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, and then cooled to room temperature, filtered through celite, washed with EA (20 mL). The filtrate was in turn washed with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 5-b (0.46 g, yield 64%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0169] Synthesis of Compound 5-a

[0170] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (0.06 g, 0.1 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (0.1 g, 0.1 mmol) were added to a solution of compound 5-b (0.36 g, 1 mmol), ethyl 2-methyl-2-mercaptopropionate (0.15 g, 1 mmol) and diisopropylethylamine (0.26 g, 2 mmol) in dioxane (8 mL), the mixture was reacted in a microwave at 110? C. for 30 mins. The mixture was cooled to room temperature, and then concentrated under reduced pressure to remove dioxane, the residue was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 5-a (0.37 g, yield 87%). LC-MS (ESI): m/z=427 [M+H].sup.+.

[0171] Synthesis of Compound 5

[0172] At room temperature, LiOH (42 mg, 1 mmol) was added to a mixed solution of compound 5-a (370 mg, 0.86 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL), the mixture was stirred for 1 h, and then 2M HCl aqueous solution (2 mL) and water (20 mL) were added, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 5 (280 mg, yield 82%). LC-MS (ESI): m/z=399 [M+H].sup.+.

[0173] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.67 (s, 1H), 9.51 (s, 1H), 8.57 (s, 1H), 8.35 (d, J=7.6 Hz, 1H), 8.27(m, 2H), 7.85 (t, J=7.6 Hz, 1H), 7.75 (d, J=7.6 Hz, 1H), 7.66 (d, J=8.0 Hz, 1H), 7.60 (t, J=8.0 Hz, 2H), 7.41 (d, J=8.0 Hz, 1H), 7.26 (s, 1H), 1.27 (s, 3H), 1.24 (s, 3H) ppm.

Embodiment 6

2{[4-(4-Cyanophenyl)isoquinolin-6-yl]oxy}-2-methylpropionic acid (Compound 6)

[0174] ##STR00096##

[0175] Synthesis of Compound 6-c

[0176] Under N.sub.2 atmosphere, bis(pinacolato)diboron (3.1 g, 12 mmol), potassium acetate (2.0 g, 20 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (0.56 g, 1 mmol) were respectively added to a solution of compound 4-b (3.1 g, 10 mmol) in dioxane (15 mL), the mixture was stirred at 80? C. for 8 hrs. The mixture was cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=1:1) to give white solid 6-c (1.76 g, yield 63%). LC-MS (ESI): m/z=275 [M+H].sup.+.

[0177] Synthesis of Compound 6-b

[0178] At 0? C., 30% H.sub.2O.sub.2 solution (2 mL) was added to a solution of compound 6-c (1.1 g, 4 mmol) in THF (20 mL), the mixture was stirred for 4 hrs before water (100 mL) was added. The mixture was extracted with EA (100 mL?3), the combined organic phases were washed in turn with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give white solid 6-b (0.5 g, yield 50%). LC-MS (ESI): m/z=247 [M+H].sup.+.

[0179] Synthesis of Compound 6-a

[0180] Under N.sub.2 atmosphere, ethyl 2-bromoisobutyrate (190 mg, 1 mmol) and potassium carbonate (138 mg, 1 mmol) were added to a solution of compound 6-b (75 mg, 0.3 mmol) in acetonitrile (4 mL), the mixture was reacted for 3 hrs at 80? C. . The mixture was cooled to room temperature, concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (8 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give yellow liquid 6-a (56 mg, yield 52%). LC-MS (ESI): m/z=361 [M+H].sup.+.

[0181] Synthesis of Compound 6

[0182] At room temperature, LiOH (42 mg, 1 mmol) was added to a mixed solution of compound 6-a (56 mg, 0.156 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL), the mixture was stirred for 1 h, followed by adding 2M HCl aqueous solution (2 mL) and water (1 mL), solid was precipitated and filtered. The solid was washed with water (5 mL), dried under vacuum to give white solid 6 (32 mg, yield 62%). LC-MS (ESI): m/z=333 [M+H].sup.+.

[0183] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 13.27 (s, 1H), 9.24 (s, 1H), 8.39 (s, 1H), 8.16 (d, J=8.0 Hz, 1H), 8.02 (d, J=8.0 Hz, 1H), 7.72 (d, J=8.0 Hz, 2H), 7.30 (d, J=8.0 Hz, 2H), 7.26 (s, 1H), 6.94 (s, 1H), 1.55 (s, 6H) ppm.

Embodiment 7

[0184] ##STR00097##

[0185] Synthesis of compound 7A-a and 7B-a

[0186] Under N.sub.2 atmosphere, ethyl 2-bromopropionate (540 mg, 3 mmol) and potassium carbonate (560 mg, 4 mmol) were added to a solution of compound 6-b (500 mg, 2 mmol) in acetonitrile (20 mL), the mixture was reacted for 6 hrs at 80? C. The mixture was cooled to room temperature, concentrated under reduced pressure, the residue was filtered through celite, the filtrate cake was washed with EA (200 mL). The filtrate was washed with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give yellow liquid, followed by separating with enantiomeric chromatographic column (process I, mobile phase: Hexane: EtOH: DEA =70:30:0.1) to give enantiomer 7A-a which is obtained firstly (80 mg, yield 11.5%; LC-MS (ESI): m/z=347 [M+H].sup.+) (T.sub.r=9.0 min) and enantiomer 7B-a which is obtained later (90 mg, yield 13%; LC-MS (ESI): m/z=347 [M+H].sup.+) (T.sub.r=11.0 min). The absolute configuration of 7A-a and 7B-a is unknown.

[0187] Synthesis of Compound 7A

[0188] At room temperature, LiOH (42 mg, 1 mmol) was added to a mixed solution of compound 7A-a (70 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL), the mixture was stirred for 1 h, followed by adding 2M HCl aqueous solution (2 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 7A (51 mg, yield 80%). LC-MS (ESI): m/z=319 [M+H].sup.+.

[0189] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 13.15 (s, 1H), 9.24 (s, 1H), 8.40 (s, 1H), 8.19 (d, J=8.0 Hz, 1H), 8.01 (d, J=8.0 Hz, 1H), 7.73 (d, J=8.0 Hz, 2H), 7.40 (d, J=8.0 Hz, 2H), 7.26 (s, 1H), 6.94 (s, 1H), 4.89 (m, 1H), 1.53 (d, J=8.0 Hz, 3H) ppm.

[0190] Synthesis of Compound 7B

[0191] At room temperature, LiOH (42 mg, 1 mmol) was added to a mixed solution of compound 7B-a (70 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL), the mixture was stirred for 1 h, followed by adding 2M HCl aqueous solution (2 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 7B (46 mg, yield 72%). LC-MS (ESI): m/z=319 [M+H].sup.+.

[0192] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 13.15 (s, 1H), 9.24 (s, 1H), 8.40 (s, 1H), 8.19 (d, J=8.0 Hz, 1H), 8.01 (d, J=8.0 Hz, 1H), 7.73 (d, J=8.0 Hz, 2H), 7.40 (d, J=8.0 Hz, 2H), 7.26 (s, 1H), 6.94 (s, 1H), 4.89 (m, 1H), 1.53 (d, J=8.0 Hz, 3H) ppm.

Embodiment 8

2{[4-(4-Cyano-2-fluorophenyl)isoquinolin-6-yl]thio}-2-methylpropionic acid (Compound 8)

[0193] ##STR00098##

[0194] Synthesis of Compound 8-b

[0195] Under N.sub.2 atmosphere, compound 4-c (330 mg, 1 mmol), 2-fluoro-4-cyanophenylboronic acid (165 mg, 1 mmol) and sodium carbonate (212 mg, 0.2 mmol) were suspended in a mixed solution of dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (56 mg, 0.1 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (20 mL). The filtrate was in turn washed with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 8-b (63 mg, yield 19%). LC-MS (ESI): m/z=387 [M+H].sup.+.

[0196] Synthesis of Compound 8-a

[0197] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (12 mg, 0.02 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (20 mg, 0.02 mmol) were added to a solution of compound 8-b (63 mg, 0.2 mmol), ethyl 2-methyl-2-mercaptopropionate (30 mg, 0.2 mmol) and diisopropylethylamine (52 mg, 0.4 mmol) in dioxane (8 mL), the mixture was reacted in a microwave at 110? C. for 30 mins. The mixture was cooled to room temperature, followed by evaporating dioxane under reduced pressure, the residue was filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 8-a (72 mg, yield 91.3%). LC-MS (ESI): m/z=395 [M+H].sup.+.

[0198] Synthesis of Compound 8

[0199] At room temperature, LiOH (42 mg, 1 mmol) was added to a mixed solution of compound 8-a (72 mg, 0.18 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 2M HCl aqueous solution (2 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 8 (16 mg, yield 24%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0200] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.8 (s, 1H), 9.44 (s, 1H), 8.54 (s, 1H), 8.23 (d, J=7.6 Hz, 1H), 8.10 (d, J=7.6 Hz, 1H), 7.92 (d, J=7.6 Hz, 1H), 7.78 (t, J=7.6 Hz, 1H), 7.70 (d, J=7.6 Hz, 1H), 7.59 (s, 1H), 1.44 (s, 6H) ppm.

Embodiment 9

2{[4-(4-Cyanonaphthalen-1-yl)-8-fluoroisoquinolin-6-yl]thio}-2-methylpropionic acid (Compound 9)

[0201] ##STR00099##

[0202] Synthesis of Compound 9-f

[0203] At 0? C., p-toluenesulfonyl chloride (4.00 g, 21 mmol) was added in portion to a solution of 5-bromo-2-fluorobenzylamine (4.08 g, 20 mmol) and triethylamine (4.04 g, 40 mmol) in DCM (60 mL). The mixture was reacted at 0? C. for 30 mins, followed by removing the ice bath, further reacting at room temperature for 16 hrs, then being concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give compound 9-f (5.30 g, yield 74%). LC-MS (ESI): m/z=358 [M+H].sup.+.

[0204] Synthesis of Compound 9-e

[0205] At room temperature, 2-bromo-1,1-diethoxyethane (3.0 g, 15 mmol), cesium carbonate (6.5 g, 20 mmol) were added to a solution of compound 9-f (3.57 g, 10 mmol) in DMF (15 mL). The mixture was reacted for 16 hrs at 80? C., concentrated under reduced pressure. The residue was purified by column chromatography (PE:EA=8:1) to give compound 9-e (3.80 g, 80%).

[0206] Synthesis of Compound 9-d

[0207] At ?5? C., compound 9-e (1.50 mg, 3.18 mmol) was added to a mixture of Al Cl.sub.3 (2.0 g, 15 mmol) in DCM (20 mL). The mixture was reacted for 16 hrs at room temperature, followed by adding 2M HCl aqueous solution (20 mL), extracted with DCM (30 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=7:1) to give compound 9-d (220 mg, yield 31%). LC-MS (ESI): m/z=226 [M+H].sup.+.

[0208] Synthesis of Compound 9-c

[0209] Compound 9-d (200 mg, 0.89 mmol) and N-iodosuccinimide (300 mg, 1.33 mmol) were dissolved in acetic acid (10 mL) and trifluoroacetic acid (2 mL), the mixture was reacted for 6 hrs at 80? C. The mixture was cooled to room temperature, concentrated under reduced pressure to remove the solvent. The residue was purified by silica column chromatography (PE:EA=8:1) to give compound 9-c (200 mg, yield 64%). LC-MS (ESI): m/z=352 [M+H].sup.+.

[0210] Synthesis of Compound 9-b

[0211] Under N.sub.2 atmosphere, compound 9-c (144 mg, 0.4 mmol), compound 3-c (111 mg, 0.4 mmol) and sodium carbonate (170 mg, 1.6 mmol) were suspended in ethylene glycol dimethyl ether (10 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (43 mg, 0.05 mmol) was added. The mixture was reacted for 4 hrs at 50? C., cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 9-b (100 mg, yield 66%). LC-MS (ESI): m/z=377 [M+H].sup.+.

[0212] Synthesis of Compound 9-a

[0213] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (30 mg, 0.033 mmol) and 4,5 -bis (diphenylphosphine))-9,9-dimethyloxacanthracene (38 mg, 0.066 mmol) were added to a solution of compound 9-b (110 mg, 0.29 mmol), ethyl 2-methyl-2-mercaptopropionate (64 mg, 0.44 mmol) and diisopropylethylamine (187 mg, 1.45 mmol) in dioxane (10 mL). The mixture was reacted for 5 hrs at 100? C., followed by cooling to room temperature, concentrating under reduced pressure to remove dioxane. The residue was purified by silica column chromatography (PE:EA=4:1) to give compound 9-a (120 mg, yield 93%). LC-MS (ESI): m/z=445 [M+H].sup.+.

[0214] Synthesis of Compound 9

[0215] At room temperature, 1M LiOH aqueous solution (2.0 mL) was added to a mixed solution of compound 9-a (100 mg, 0.22 mmol) in methanol (8 mL) and THF (8 mL). The mixture was stirred at room temperature for 16 hrs, followed by being concentrated under reduced pressure. The residue was dissolved with water (10 mL), adjusted to pH=3 with 1M citric acid aqueous solution, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 9 (70 mg, yield 76%). LC-MS (ESI): m/z=417 [M+H].sup.+.

[0216] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.79 (s, br., 1H), 9.61 (s, 1H), 8.68 (s, 1H), 8.35 (d, J=8.0 Hz, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.86 (d, J=7.2 Hz, 1H), 7.75 (d, J=8.0 Hz, 1H), 7.60 (t, J=8.0 Hz, 1H), 7.51 (d, J=10.4 Hz, 1H), 7.42 (d, J=11.2 Hz, 1H), 7.07 (s, 1H), 1.29 (s, 3H), 1.22 (s, 3H) ppm.

Embodiment 10

[0217] 2{[4-(5-Cyanonaphthalen-1-yl)isoquinolin-6-yl]thio}-2-methylpropionic acid (Compound 10)

##STR00100##

[0218] Synthesis of Compound 10-e

[0219] 5-Bromo-1-naphthoic acid (980 mg, 3.92 mmol) was added to thionyl chloride (5 mL). The mixture was stirred at 85? C. for 2 hrs, concentrated under reduced pressure. The residue was dissolved in anhydrous THF (10 mL), the solution was added dropwise into 25%-28% aqueous ammonia (20 mL) at 0? C. The mixture was warmed to room temperature and further stirred for 2 hrs, followed by being extracted with EA (60 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give white solid 10-e (950 mg, yield 97%).

[0220] The product was used directly for the next step without further purification. LC-MS (ESI): m/z=250 [M+H].sup.+.

[0221] Synthesis of Compound 10-d

[0222] At 0? C., trifluoroacetic anhydride (3.2 g, 15.1 mmol) was added dropwise to a solution of compound 10-e (0.94 g, 3.78 mmol) and triethylamine (1.53 g, 15.1 mmol) in THF (8 mL). The mixture was slowly warmed to room temperature and further reacted for 3 hrs, and then concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 10-d (0.85 g, yield 97%). LC-MS (ESI): m/z=232 [M+H].sup.+.

[0223] Synthesis of Compound 10-c

[0224] Under N.sub.2 atmosphere, bis(pinacolato)diboron (1.32 g, 5.2 mmol), potassium acetate (1.0 g, 10.38 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (0.253 g, 0.346 mmol) were added respectively to a solution of compound 10-d (0.8 g, 3.46 mmol) in dioxane (15 mL). The mixture was stirred at 80? C. for 6 hrs, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 10-c (0.85 g, yield 88%). LC-MS (ESI): m/z=280 [M+H].sup.+.

[0225] Synthesis of Compound 10-b

[0226] Under N.sub.2 atmosphere, compound 10-c (200 mg, 0.72 mmol), compound 4-c (200 mg, 0.6 mmol) and sodium carbonate (130 mg, 1.2 mmol) were suspended in dioxane (20 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (50 mg, 0.06 mmol) was added. The mixture was reacted for 2 hrs at 80? C., cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (20 mL), the filtrate was concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 10-b (50 mg, yield 81%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0227] Synthesis of Compound 10-a

[0228] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (16 mg, 0.015 mmol) and 4,5-bis(bis(diphenylphosphine)-9,9-dimethyloxacanthracene (17 mg, 0.03 mmol) were added to a solution of compound 10-b (53 mg, 0.15 mmol), ethyl 2-methyl-2-mercaptopropionate (28 mg, 0.19 mmol) and diisopropylethylamine (38 mg, 0.29 mmol) in dioxane (5 mL). The mixture was reacted for 6 hrs at 100? C., cooled to room temperature, followed by being concentrated under reduced pressure to remove dioxane. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 10-a (45 mg, yield 71%). LC-MS (ESI): m/z=427 [M+H].sup.+.

[0229] Synthesis of Compound 10

[0230] At room temperature, 1M NaOH aqueous solution (2.5 mL) was added to a solution of compound 10-a (59 mg, 0.14 mmol) in methanol (5 mL), the mixture was stirred for 5 hrs, followed by adding 1M HCl aqueous solution to adjust pH=6, being concentrated under reduced pressure to remove methanol, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 10 (43 mg, yield 78%). LC-MS (ESI): m/z=399 [M+H].sup.+.

[0231] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.63 (s, 1H), 9.50 (s, 1H), 8.56 (s, 1H), 8.28 (m, 3H), 7.99 (m, 1H), 7.78 (d, J=6.3 Hz, 1H), 7.61 (m, 3H), 7.26 (s, 1H), 1.29 (s, 3H), 1.23 (s, 3H) ppm.

Embodiment 11

2-{[4-(8-Cyano-2,3-dihydro-1,4-benzodioxan-5-yl)isoquinolin-6-yl]thio }-2-methylpropionic acid (Compound 11)

[0232] ##STR00101##

[0233] Synthesis of Compound 11-f

[0234] At room temperature, diphenyl phosphoryl azide (8.02 g, 29 mmol) and triethyl amine (4.2 g, 42 mmol) were added to a solution of 2,3-dihydro-1,4-benzodioxane-5-carboxylic acid (5.0 g, 28 mmol) in anhydrous THF (110 mL). The mixture was stirred for 2 hrs, followed by adding water (30 mL), heating to 70? C. and further reacting for 3 hrs, then cooling to room temperature, being extracted with EA (100 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give compound 11-f (1.58 g, yield 37%). LC-MS (ESI): m/z=152 [M+H].sup.+.

[0235] Synthesis of Compound 11-e

[0236] At 0? C., a solution of N-bromosuccinimide (1.73 g, 9.73 mmol) in acetonitrile (5 mL) was added to a solution of compound 11-f (1.4 g, 9.27 mmol) in acetonitrile (35 mL). The mixture was warmed to room temperature and reacted for 3 hrs, evaporated under reduced pressure to remove the solvent. The residue was purified by silica column chromatography (PE:EA=10:1 to 5:1) to give compound 11-e (1.63 g, yield 77%). LC-MS (ESI): m/z=230 [M+H].sup.+.

[0237] Synthesis of Compound 11-d

[0238] At 0? C., sodium nitrite (0.5 g, 7.2 mmol) was slowly added to a suspension of compound 11-e (1.5 g, 6.55 mmol) in 3M HCl aqueous solution (12 mL), reacted for 30 mins, sodium bicarbonate solid was added to adjust the reaction mixture to pH=7. The mixture was heated to 60? C., a solution of CuCN (0.7 g, 7.86 mmol) and KCN (1.06 g, 16.37 mmol) in water (20 mL) was added dropwise, and further stirred for 30 mins. The reaction solution was cooled to room temperature, extracted with DCM (60 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE: EA=10:1) to give compound 11-d (1.2 g, yield 77%). LC-MS (ESI): m/z=240 [M+H].sup.+.

[0239] Synthesis of Compound 11-c

[0240] At ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (1.7 mL, 4.2 mmol) was added dropwise to a solution of compound 11-d (910 mg, 3.8 mmol) in anhydrous THF (20 mL), the mixture was stirred for 1 h, followed by adding trimethyl borate (594 mg, 5.7 mmol) to the reaction solution. The reaction solution was slowly warmed to room temperature, further stirred for 16 hrs, saturated NaCl aq. solution (20 mL) was added. Organic phase was seperated, the aqueous phase was extracted with EA (60 mL?3). The combined organic phases were dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure to give yellow solid 11-c (700 mg, yield 90%). The product was directly used for the next step without further purification. LC-MS (ESI): m/z=206 [M+H].sup.+.

[0241] Synthesis of Compound 11-b

[0242] Under N.sub.2 atmosphere, compound 11-c (130 mg, 0.63 mmol), compound 4-c (200 mg, 0.6 mmol) and cesium carbonate (390 mg, 1.2 mmol) were suspended to a mixture of dioxane (10 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (43 mg, 0.06 mmol) was added. The mixture was reacted for 10 hrs at 80? C., cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (20 mL), the filtrate was concentrated under reduced pressure. The residue was purified by silica preparative plate chromatography (PE:EA=3:1) to give compound 11-b (146 mg, yield 66%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0243] Synthesis of Compound 11-a

[0244] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (36 mg, 0.04 mmol) and 4,5-bis(diphenylphosphine)9,9-dimethyloxacanthracene (46 mg, 0.08 mmol) were added to a solution of compound 11-b (146 mg, 0.52 mmol), ethyl 2-methyl-2-mercaptopropionate (77 mg, 0.52 mmol) and diisopropylethylamine (103 mg, 0.8 mmol) in dioxane (8 mL). The mixture was stirred for 6 hrs at 100? C., cooled to room temperature, concentrated under reduced pressure to remove dioxane. The residue was purified by silica preparative plate chromatography (PE:EA=1:2) to give compound 11-a (147 mg, yield 85%). LC-MS (ESI): m/z=435 [M+H].sup.+.

[0245] Synthesis of Compound 11

[0246] At room temperature, 1M NaOH aq. solution (2.5 mL) was added to a solution of compound 11-a (146 mg, 0.34 mmol) in methanol (5 mL), the mixture was stirred for 5 hrs. The mixture was adjusted to pH=6 with 1M HCl aq. solution, concentrated under reduced pressure to remove methanol, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 11 (95 mg, yield 69%). LC-MS (ESI): m/z=407 [M+H].sup.+.

[0247] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.79 (s, 1H), 9.36 (s, 1H), 8.56 (s, 1H), 8.42 (s, 1H), 8.17 (d, J=8.0 Hz, 1H), 7.63 (m, 2H), 7.46 (d, J=8.0 Hz, 1H), 7.04 (d, J=8.0 Hz, 1H), 4.47 (m, 2H), 4.23 (m, 2H), 1.47 (s, 3H), 1.44 (s, 3H) ppm.

Embodiment 12

2-{[4-(4-Cyano-7-fluoronaphthalen-1-yl)isoquinolin-6-yl]thio}-2-methyl propionic acid (Compound 12)

[0248] ##STR00102##

[0249] Synthesis of Compound 12-f

[0250] At room temperature, diphenyl phosphoryl azide (7.6 g, 27.6 mmol) and triethyl amine (4.0 g, 54 mmol) were added to a solution of 6-fluoronaphthalene-1-carboxylic acid (5.0 g, 26.3 mmol) in anhydrous THF (60 mL). The mixture was stirred for 2 hrs, followed by adding water (30 mL), heating to 70? C. and further stirring for 3 hrs. The reaction solution was cooled to room temperature, extracted with EA (150 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=15:1) to give compound 12-f (1.0 g, yield 16%). LC-MS (ESI): m/z=162 [M+H].sup.+.

[0251] Synthesis of Compound 12-e

[0252] At 0? C., a solution of N-bromosuccinimide (1.55 g, 8.7 mmol) in DCM (5 mL) was added dropwise to a solution of compound 12-f (1.4 g, 8.7 mmol) in DCM (50 mL). The reaction solution was stirred for 30 mins, concentrated under reduced pressure to remove the solvent. The residue was purified by silica column chromatography (PE:EA=15:1) to give compound 12-e (1.45 g, yield 70%). LC-MS (ESI): m/z=240 [M+H].sup.+.

[0253] Synthesis of Compound 12-d

[0254] At 0? C., sodium nitrite (0.5 g, 7.2 mmol) was slowly added to a suspension of compound 12-e (800 mg, 3.3 mmol) in 3M HCl aqueous solution (12 mL), the mixture was reacted for 30 mins, sodium bicarbonate solid was added to adjust the reaction solution to pH=7. At 60? C., the mixture was added to a solution of CuCN (357 mg, 4.0 mmol) and KCN (536 mg, 8.25 mmol) in water (20 mL), the mixture was further reacted for 30 mins The reaction solution was cooled to room temperature, extracted with DCM (60 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give compound 12-d (420 mg, yield 50%). LC-MS (ESI): m/z=250 [M+H].sup.+.

[0255] Synthesis of Compound 12-c

[0256] At ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (0.5 mL, 1.17 mmol) was added dropwise to a solution of compound 12-d (226 mg, 0.9 mmol) in anhydrous THF (10 mL). The mixture was stirred for 1 h, followed by adding trimethyl borate (142 mg, 1.36 mmol) dropwise, then slowly warming to room temperature, and further stirring for 16 hrs, 1M HCl aqueous solution (5 mL) was added. The organic phase was seperated, the aqueous phase was extracted with EA (30 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give yellow solid 12-c (200 mg, yield 100%). The product was directly used for the next step without further purification. LC-MS (ESI): m/z=216 [M+H].sup.+.

[0257] Synthesis of Compound 12-b

[0258] Under N.sub.2 atmosphere, compound 12-c (120 mg, 0.93 mmol), compound 4-c (223 mg, 1.11 mmol) and cesium carbonate (363 mg, 1.11 mmol) were suspended in a mixture of dioxane (8 mL) and water (0.8 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (41 mg, 0.056 mmol) was added. The mixture was reacted for 5 hrs at 80? C., cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (20 mL). The filtrate was concentrated under reduced pressure, the residue was purified by silica preparative plate chromatography (PE:EA=1:1) to give compound 12-b (90 mg, yield 43%). LC-MS (ESI): m/z=377 [M+H].sup.+.

[0259] Synthesis of Compound 12-a

[0260] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (22 mg, 0.02 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (28 mg, 0.05 mmol) were added to a solution of compound 12-b (90 mg, 0.24 mmol), ethyl 2-methyl-2-mercaptopropionate (46 mg, 0.3 mmol) and diisopropylethylamine (62 mg, 0.48 mmol) in dioxane (8 mL). The mixture was stirred for 6 hrs at 100? C., cooled to room temperature, concentrated under reduced pressure to remove dioxane. The residue was purified by silica preparative plate chromatography (PE:EA=1:1) to give compound 12-a (100 mg, yield 94%). LC-MS (ESI): m/z=445 [M+H].sup.+.

[0261] Synthesis of Compound 12

[0262] At room temperature, 1M NaOH aq. solution (2.5 mL) was added to a solution of compound 12-a (100 mg, 0.22 mmol) in methanol (5 mL), the mixture was stirred for 10 hrs. The mixture was adjusted to pH=6 with 1M HCl aq. solution, concentrated under reduced pressure to remove methanol, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 12 (70 mg, yield 75%). LC-MS (ESI): m/z=417 [M+H].sup.+.

[0263] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.69 (s, 1H), 9.51 (s, 1H), 8.68 (s, 1H), 8.47 (d, J=8.5 Hz, 1H), 8.29 (m, 2H), 8.12 (m, 1H), 7.83 (m, 2H), 7.73 (d, J=8.5 Hz, 1H), 7.61 (s, 1H), 1.41 (s, 3H), 1.40 (s, 3H) ppm.

Embodiment 13

3-[4-(4-Cyanophenyl)isoquinolin-6-yl]butyric acid (Compound 13)

[0264] ##STR00103## ##STR00104##

[0265] Synthesis of Compound 13-e

[0266] Under N.sub.2 atmosphere, bis(pinacolato)diboron (4.53 g, 17.82 mmol), potassium acetate (4.37 g, 44.55 mmol) and palladium acetate (0.17 g, 0.74 mmol) were added respectively to a solution of 1-bromo-4-nitrobenzene (3.0 g, 14.85 mmol) in DMF (10 mL). The mixture was stirred at 80? C. for 2 hrs, followed by adding water (20 mL) and EA (20 mL), the organic phase was in turn washed with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 13-e (2 g, yield 54%). LC-MS (ESI): m/z=250 [M+H].sup.+.

[0267] Synthesis of Compound 13-d

[0268] Under N.sub.2 atmosphere, compound 4-c (1.0 g, 3 mmol), compound 13-e (0.82 g, 3.3 mmol) and sodium carbonate (0.95 g, 8.98 mmol) were suspended in DMF (10 mL) and water (5 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (0.245 g, 0.3 mmol) was added. The mixture was stirred at 80? C. for 2 hrs, cooled to room temperature, followed by adding water (15 mL), being extracted with EA (30 mL?3). The organic phase was in turn washed with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 13-d (0.9 g, yield 90%). LC-MS (ESI): m/z=329 [M+H].sup.+.

[0269] Synthesis of Compound 13-c

[0270] Under N.sub.2 atmosphere, methyl crotonate (0.29 mL, 2.7 mmol), palladium acetate (41 mg, 0.18 mmol), tri-o-methylphenylphosphine (111 mg, 0.36 mmol) and triethyl amine (0.5 mL, 3.6 mmol) were added to a solution of compound 13-d (600 mg, 1.8 mmol) in DMF (5 mL). The mixture was stirred for 16 hrs at 80? C., cooled to room temperature, followed by adding water (15 mL) and being extracted with EA (30 mL?3). The organic phase was washed with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 13-c (360 mg, yield 57%). LC-MS (ESI): m/z=349 [M+H].sup.+.

[0271] Synthesis of Compound 13-b

[0272] Under H.sub.2 atmosphere (1 atm.), PdC (100 mg) was added to a solution of compound 13-c (180 mg, 0.51 mmol) in ethanol (20 mL). The mixture was stirred for 16 hrs at room temperature, filtered, concentrated under reduced pressure. The residue was purified by silica chromatography (PE:EA=1:1) to give compound 13-b (360 mg, yield 57%). LC-MS (ESI): m/z=321 [M+H].sup.+.

[0273] Synthesis of Compound 13-a

[0274] At 0 , sodium nitrite (14.2 mg, 0.2 mmol) was slowly added to a suspension of compound 13-b (60 mg, 0.18 mmol) in concentrated HCl aqueous solution (1 mL), the mixture was stirred for 30 mins, sodium bicarbonate solid was added to adjust the reaction solution to pH=7. The mixture was heated to 60? C., then was added to a solution of CuCN (20.1 mg, 0.22 mmol) and KCN (30.5 mg, 0.46 mmol) in water (3 mL), further reacted for 30 mins The reaction solution was cooled to room temperature, extracted with DCM (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give compound 13-a (30 mg, yield 48%). LC-MS (ESI): m/z=331 [M+H].sup.+.

[0275] Synthesis of Compound 13

[0276] At room temperature, LiOH (50 mg, 2 mmol) was added to a mixed solution of compound 13-a (30 mg, 0.09 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, followed by being adjusted to pH=7 with 2M HCl aq. solution and then extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure to give compound 13 (10 mg, yield 35%). LC-MS (ESI): m/z=317 [M+H].sup.+.

[0277] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.10 (s, 1H), 9.34 (s, 1H), 8.44 (s, 1H), 8.20 (d, J=8.8 Hz, 1H), 8.05 (d, J=8.0 Hz, 2H), 7.77 (d, J=8.0 Hz, 2H), 7.74 (d, J=8.8 Hz, 2H), 7.62 (s, 1H), 3.30 (m, 1H), 2.57 (d, J=7.6 Hz, 2H), 1.26 (d, J=8.8 Hz, 3H) ppm.

Embodiment 14

(2E)-3-[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]acrylic acid (Compound 14)

[0278] ##STR00105##

[0279] Synthesis of Compound 14-a

[0280] Under N.sub.2 atmosphere, methyl acrylate (0.189 mL, 2.09 mmol), palladium acetate (31.2 mg, 0.14 mmol), tri-o-methylphenylphosphine (85 mg, 0.27 mmol) and triethyl amine (0.39 mL, 2.78 mmol) were added to a solution of compound 5-b (500 mg, 1.39 mmol) in DMF (5 mL). The mixture was stirred at 80? C. for 16 hrs, cooled to room temperature, followed by adding water (15 mL), being extracted with EA (30 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=1:1) to give compound 14-a (400 mg, yield 79%). LC-MS (ESI): m/z=379 [M+H].sup.+.

[0281] Synthesis of Compound 14

[0282] At room temperature, LiOH (52.6 mg, 2.19 mmol) was added to a mixed solution of compound 14-a (80 mg, 0.22 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, adjusted to pH=7 with 2M HCl aq. solution, extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure to give compound 14 (68 mg, yield 88%). LC-MS (ESI): m/z=351 [M+H].sup.+.

[0283] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.60 (s, 1H), 9.51 (s, 1H), 8.55 (s, 1H), 8.24 (m, 3H), 8.13 (d, J=8.4 Hz, 1H), 7.85 (t, J=7.6 Hz, 1H), 7.75 (d, J=7.6 Hz, 1H), 7.51 (m, 4H), 6.61 (d, J=15.6 Hz, 1H) ppm.

Embodiment 15

3-[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]butyric acid (Compound 15)

[0284] ##STR00106##

[0285] Synthesis of Compound 15-b

[0286] Under N.sub.2 atmosphere, methyl crotonate (72 mg, 0.56 mmol), palladium acetate (12.5 mg, 0.05 mmol), tri-o-methylphenylphosphine (34 mg, 0.11 mmol) and triethyl amine (0.15 mL, 1.11 mmol) were added to a solution of compound 5-b (200 mg, 0.56 mmol) in DMF (5 mL). The mixture was stirred at 80? C. for 16 hrs, cooled to room temperature, followed by adding water (10 mL), being extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 15-b (120 mg, yield 59%). LC-MS (ESI): m/z=379 [M+H].sup.+.

[0287] Synthesis of Compound 15-a

[0288] At 0? C., NaBH.sub.4 (120 mg, 3.17 mmol) was slowly added to a solution of compound 15-b (120 mg, 0.31 mmol) and NiCl.sub.2 (102 mg, 0.79 mmol) in methanol (150 mL). The mixture was stirred at 0? C. for 4.5 hrs, warmed to room temperature, and concentrated under reduced pressure, followed by adding water (20 mL) to the residue, being extracted with EA (50 mL?3). The organic phases were combined, washed in turn with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=2:1) to give compound 15-a (45 mg, yield 37%). LC-MS (ESI): m/z=381 [M+H].sup.+.

[0289] Synthesis of Compound 15

[0290] At room temperature, LiOH (28.3 mg, 1.18 mmol) was added to a mixed solution of compound 15-a (45 mg, 0.11 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, and then adjusted to pH=7 with 2M HCl aq. solution, extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure to give compound 15 (18 mg, yield 42%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0291] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.25 (s, 1H), 8.31 (s, 1H), 8.25 (d, J=8.4 Hz, 1H), 8.12 (d, J=4.4 Hz, 1H), 8.09 (d, J=7.2 Hz, 1H), 7.70 (t, J=7.2 Hz, 1H), 7.59 (m, 2H), 7.44 (m, 1H), 7.35 (t, J=8.8 Hz, 1H), 7.04 (d, J=10 Hz, 1H), 3.12 (m, 1H), 2.36 (m, 1H), 1.07 (m,3H) ppm.

Embodiment 16

3-[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]-2-methyl propionic acid (Compound 16)

[0292] ##STR00107##

[0293] Synthesis of Compound 16-b

[0294] At 0? C., NaBH.sub.4 (145 mg, 3.84 mmol) was slowly added to a solution of compound 14-a (350 mg, 0.96 mmol) and NiCl.sub.2 (62.2 mg, 0.48 mmol) in methanol (150 mL). The mixture was stirred at 0? C. for 4.5 hrs, warmed to room temperature, and concentrated under reduced pressure, followed by adding water (20 mL) to the residue, being extracted with EA (50 mL?3). The organic phases were combined, washed in turn with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=2:1) to give compound 16-b (200 mg, yield 57%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0295] Synthesis of Compound 16-a

[0296] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (0.87 mL, 2.18 mmol) was added dropwise in a solution of diisopropylamine (0.11 mL, 2.18 mmol) in anhydrous THF (10 mL). The mixture was stirred for 30 mins, a solution of compound 16-b (200 mg, 0.55 mmol) in anhydrous THF (5 mL) was added dropwise, and the mixture was further stirred for 30 mins, a solution of CH.sub.3I (139.5 mg, 0.98 mmol) in anhydrous THF (5 mL) was added dropwise, the mixture was slowly warmed to room temperature and further stirred for 2 hrs, saturated NH.sub.4Cl aq. solution (10 mL) was added, the mixture was extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 16-a (20 mg, yield 19%). LC-MS (ESI): m/z=381 [M+H].sup.+.

[0297] Synthesis of Compound 16

[0298] At room temperature, LiOH (25 mg, 1.05 mmol) was added to a mixed solution of compound 16-a (20 mg, 0.05 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, adjusted to pH=7 with 2M HCl aq. solution, extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure to give compound 16 (10 mg, yield 52%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0299] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.37 (s, 1H), 8.42 (d, J=2.4 Hz, 1H), 8.36 (d, J=8.4 Hz, 1H), 8.21 (m, 2H), 7.81 (t, J=7.6 Hz, 1H), 7.69 (d, J=7.6 Hz, 1H), 7.66 (d, J=8.4 Hz, 1H), 7.50 (m, 2H), 7.13 (d, J=7.6 Hz, 1H), 2.97 (m, 1H), 2.65 (m, 2H), 1.02 (m,3H) ppm.

Embodiment 17

3-[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]-2,2-dimethyl propionic acid (Compound 17)

[0300] ##STR00108##

[0301] Synthesis of Compound 17-a

[0302] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (0.87 mL, 2.18 mmol) was slowly added to a solution of diisopropylamine (0.11 mL, 2.18 mmol) in anhydrous THF (10 mL) dropwise. The mixture was stirred for 30 mins, followed by adding a solution of compound 16-b (200 mg, 0.55 mmol) in anhydrous THF (5 mL) dropwise, further stirred for 30 mins, followed by adding a solution of CH.sub.3I (139.5 mg, 0.98 mmol) in anhydrous THF (5 mL). The mixture was slowly warmed to room temperature, further stirred for 2 hrs, followed by adding saturated NH.sub.4Cl aq. solution (10 mL) and being extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 17-a (20 mg, yield 18.5%). LC-MS (ESI): m/z=395 [M+H].sup.+.

[0303] Synthesis of compound 17

[0304] At room temperature, LiOH (24 mg, 1.01 mmol) was added to a mixed solution of compound 17-a (20 mg, 0.05 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, followed by adding 2M HCl aq. solution to adjust pH=7, and then extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over magnesium sulfate, filtered, concentrated under reduced pressure to give compound 17 (5 mg, yield 26%). LC-MS (ESI): m/z=381 [M+H].sup.+.

[0305] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.37 (s, 1H), 8.42 (s, 1H), 8.37 (d, J=8.8 Hz, 1H), 8.21 (d, J=7.6 Hz, 1H), 7.81 (m, 1H), 7.55 (m, 5H), 7.11 (s, 1H), 2.97 (m, 1H), 2.89 (m, 2H), 1.02 (s, 3H), 0.97 (s, 3H) ppm.

Embodiment 18

2-{[8-(4-Cyanophenyl)isoquinolin-2-yl]thio}-2-methyl propionic acid (Compound 18)

[0306] ##STR00109##

[0307] Synthesis of Compound 18-b

[0308] 8-Bromo-2-chloroquinazoline (110 mg, 0.45 mmol) was added to a suspension of ethyl 2-methyl-2-mercaptopropionate (80 mg, 0.54 mmol), potassium carbonate (124 mg, 0.9 mmol) in DMF (3 mL). The mixture was stirred for 3 hrs at 130? C., cooled to room temperature, followed by adding water (20 mL), being extracted with EA (30 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=6:1) to give colorless oil 18-b (108 mg, yield 67.5%). LC-MS (ESI): m/z=355 [M+H].sup.+.

[0309] Synthesis of compound 18-a

[0310] Under N.sub.2 atmosphere, compound 18-b (108 mg, 0.3 mmol), 4-cyanophenyl boronic acid (54 mg , 0.36 mmol) and cesium carbonate (196 mg, 0.6 mmol) were suspended in dioxane (10 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 90? C. for 16 hrs, followed by cooling to room temperature, being concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give colorless oil 18-a (83 mg, yield 72%). LC-MS (ESI): m/z=378 [M+H].sup.+.

[0311] Synthesis of Compound 18

[0312] At room temperature, 1M NaOH aq. solution (2.0 mL) was added to a solution of compound 18-a (83 mg, 0.22 mmol) in methanol (5 mL). The mixture was stirred for 2 hrs, followed by adding 1M HCl aq. solution to adjust pH=5-6, being extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by HPLC (mobile phase: 10 mM NH.sub.4HCO.sub.3 aq. solution: acetonitrile=25%-55%) to give yellow solid 18 (7 mg, yield 9%). LC-MS (ESI): m/z=350 [M+H].sup.+.

[0313] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.31 (s, 1H), 8.07 (dd, J=8.0 Hz, 1.6 Hz, 1H), 7.98 (dd, J=7.6 Hz, 2.4 Hz, 1H), 7.84 (d, J=7.6 Hz, 2H), 7.77 (d, J=7.6 Hz, 2H), 7.71 (dd, J=7.8 Hz, 3.6 Hz, 1H), 1.68 (s, 6H) ppm.

Embodiment 19

{[4-(4-Cyanophenyl)isoquinolin-6-yl](methyl)carbamoyl}formic acid (Compound 19)

[0314] ##STR00110##

[0315] Synthesis of compound 19-g

[0316] Under CO atmosphere (10 atm.), a mixture of 6-bromoisoquinoline (5.0 g, 24 mmol), sodium acetate (2.56 g, 31 mmol), tetrakis(triphenylphosphine)palladium (2.77 g, 2.4 mmol), palladium acetate (1.1 g, 4.8 mmol), DMF (50 mL) and DCM (50 mL) was heated to 100? C., stirred for 16 hrs and then cooled to room temperature, concentrated under reduced pressure to remove methanol. Water (100 mL) was added to the residue, EA (200 mL?2) was used for extract. The organic phases were combined, washed in turn with water (100 mL?3) and saturated brine (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give white solid 19-g (4.34 g, yield 96%). LC-MS (ESI): m/z=188 [M+H].sup.+.

[0317] Synthesis of Compound 19-f

[0318] N-Bromosuccinimide (6.19 g, 34.8 mmol), compound 19-g (4.34 g, 23.2 mmol) and acetic acid (25 mL) were added to 80? C. and stirred for 16 hrs, the mixture was cooled to room temperature, concentrated under reduced pressure. Saturated sodium bicarbonate solution was added to the residue (30 mL), the mixture was extracted with EA (50 mL?2). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica chromatography (PE:EA=5:1) to give compound 19-f (3.59 g, yield 58%). LC-MS (ESI): m/z=268 [M+H].sup.+.

[0319] Synthesis of Compound 19-e

[0320] At room temperature, 2M NaOH aq. solution (10 mL) was added to a solution of compound 19-f (3.59 g, 13.5 mmol) in methanol (30 mL). The mixture was stirred for 16 hrs, followed by adding 1M HCl aq. solution to adjust pH=5-6, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give yellow solid 19-e (3.29 g, yield 96.8%). LC-MS (ESI): m/z=254 [M+H].sup.+.

[0321] Synthesis of Compound 19-d

[0322] At room temperature, diphenyl phosphoryl azide (5.2 g, 25.2 mmol) and triethyl amine (2.5 g, 25.2 mmol) were added to a solution of compound 19-e (3.17 g, 12.6 mmol) in anhydrous THF (30 mL). The mixture was stirred for 3 hrs, followed by adding water (10 mL), refluxing for 12 hrs, then cooling to room temperature, being concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give yellow solid 19-g (0.2 g, yield 7%). LC-MS (ESI): m/z=225 [M+H].sup.+.

[0323] Synthesis of Compound 19-c

[0324] Sodium methoxide (218 mg, 4.03 mmol) and polyformaldehyde (121 mg, 4.03 mmol) were added to a solution of compound 19-d (180 mg, 0.81 mmol) in methanol (6 mL). The mixture was refluxed for 1.5 hrs, cooled to 0? C., NaBH.sub.4 (185 mg, 4.86 mmol) was added in portions. The mixture was refluxed again for 1.5 hrs, then cooled to room temperature, saturated NaHCO.sub.3 (30 mL) was added, the mixture was extracted with DCM (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure to give yellow solid 19-c (175 mg, yield 91.6%), the product was directly used for the next step without further purification. LC-MS (ESI): m/z=237 [M+H].sup.+.

[0325] Synthesis of Compound 19-b

[0326] At room temperature, ethyl oxalyl monochloride (151 mg, 1.11 mmol) was added to a solution of compound 19-c (175 mg, 0.74 mmol) and triethyl amine (150 mg, 1.48 mmol) in DCM (10 mL). The mixture was stirred for 1 h, followed by adding water (10 mL), being extracted with DCM (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure to give yellow oil 19-b (249 mg, yield 99%), the product was directly used for the next step without further purification. LC-MS (ESI): m/z=339 [M+H].sup.+.

[0327] Synthesis of Compound 19-a

[0328] Under N.sub.2 atmosphere, compound 19-b (249 mg, 0.74 mmol), 4-cyanophenylboronic acid (163 mg, 1.11 mmol) and sodium carbonate (157 mg, 1.48 mmol) were suspended in dioxane (15 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (54 mg, 0.07 mmol) was added. The mixture was stirred at 90? C. for 12 hrs, followed by cooling to room temperature, being concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1-1:1) to give compound 19-a (90 mg, yield 34%). LC-MS (ESI): m/z=360 [M+H].sup.+.

[0329] Synthesis of Compound 19

[0330] At room temperature, LiOH (2.0 mL) was added to a solution of compound 19-a (90 mg, 0.25 mmol) in methanol (5 mL), THF (3 mL) and water (1 mL). The reaction solution was stirred for 2 hrs, and then concentrated under reduced pressure. The residue was adjusted to pH=5-6 with 1M HCl aq. solution, then extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, concentrated under reduce pressure. The residue underwent HPLC preparation (mobile phase: 10 mM NH.sub.4HCO.sub.3 aq. solution: acetonitrile=25%-55%) to give white solid 19 (5 mg, yield 7%). LC-MS (ESI): m/z=332 [M+H].sup.+.

[0331] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.34 (s, 1H), 8.47 (s, 1H), 8.31 (d, J=8.6 Hz, 1H), 7.96 (d, J=8.6 Hz, 1H), 7.80 (m, 4H), 3.39 (s, 3H) ppm.

Embodiment 20

{[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl](methyl)carbamoyl}formic acid (Compound 20)

[0332] ##STR00111##

[0333] Synthesis of Compound 20

[0334] Under N.sub.2 atmosphere, compound 19-b (260 mg, 0.77 mmol), compound 3-c (258 mg, 0.93 mmol) and sodium carbonate (163 mg, 1.54 mmol) were suspended in dioxane (8 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (56 mg, 0.07 mmol) was added. The mixture was stirred at 90? C. for 12 hrs, followed by cooling to room temperature, being concentrated under reduced pressure. The residue underwent HPLC preparation (mobile phase: 10 mM NH.sub.4HCO.sub.3 aq. solution: acetonitrile=25%-45%) to give yellow solid 20 (40 mg, yield 13.6%). LC-MS (ESI): m/z=382 [M+H].sup.+.

[0335] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.42 (s, 1H), 8.47 (s, 1H), 8.33 (d, J=8.7 Hz, 2H), 8.20 (d, J=7.3 Hz, 1H), 7.79 (dd, J=8.6 Hz, 4.8 Hz, 1H), 7.71 (d, J=7.3 Hz, 1H), 7.56 (m, 2H), 7.33 (d, J=1.4 Hz, 2H), 3.24 (s, 3H) ppm.

Embodiment 21

2-{[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]thio}propionic acid (Compound 21)

[0336] ##STR00112##

[0337] Synthesis of Compound 21-a

[0338] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (24 mg, 0.05 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (30 mg, 0.05 mmol) were added to a solution of compound 5-b (185 mg, 0.51 mmol), ethyl 2-mercaptopropionate (83 mg, 0.61 mmol) and diisopropylethylamine (133 mg, 1.03 mmol) in dioxane (6 mL). The mixture was reacted in a microwave at 110? C. for 1 h, cooled to room temperature, and then concentrated under reduced pressure to remove dioxane. The residue was purified by silica column chromatography (PE:EA=3:2) to give yellow solid 21-a (163 mg, yield 77%). LC-MS (ESI): m/z=413 [M+H].sup.+.

[0339] Synthesis of Compound 21

[0340] At room temperature, LiOH (12 mg, 0.29 mmol) was added to a solution of compound 21-a (30 mg, 0.07 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution to adjust pH=5-6, the mixture was extracted with EA (15 mL?2). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure to give white solid 21 (16 mg, yield 57%). LC-MS (ESI): m/z=385 [M+H].sup.+.

[0341] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.43 (s, 1H), 8.50 (s, 1H), 8.27 (m, 3H), 7.85 (s, 1H), 7.72 (dd, J=11.7 Hz, 7.5 Hz, 2H), 7.59 (d, J=7.2 Hz, 1H), 7.45 (d, J=9.0 Hz, 1H), 7.15 (d, J=10.1 Hz, 1H), 1.35 (s, 1H), 1.24 (m, 3H) ppm.

Embodiment 22

2-{[4-(3-Chloro-4-cyanophenyl)isoquinolin-6-yl]thio}-2-methyl propionic acid (Compound 22)

[0342] ##STR00113##

[0343] Synthesis of Compound 22-c

[0344] Under N.sub.2 atmosphere, bis(pinacolato)diboron (391 mg, 1.54 mmol), potassium acetate (412 mg, 4.2 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (102 mg, 0.14 mmol) were respectively added to a solution of 2-chloro-4-bromobenzonitrile (300 mg, 1.4 mmol) in dioxane (15 mL). The mixture was stirred at 115? C. for 12 hrs, cooled to room temperature, filtered through celite, washed with EA (50 mL). The filtrate was evaporated under reduced pressure to give compound 22-c (620 mg, yield 100%). The product was directly used for the next step without further purification. LC-MS (ESI): m/z=182 [M+H].sup.+.

[0345] Synthesis of Compound 22-b

[0346] Compound 4-c (80 mg, 0.24 mmol) was added to a suspension of ethyl 2-methyl-2-mercaptopropionate (71 mg, 0.48 mmol) and potassium carbonate (100 mg, 0.72 mmol) in DMF (2 mL). The mixture was stirred at 130? C. for 2 hrs, cooled to room temperature, followed by adding water (20 mL), being extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified with silica preparative plate (PE:EA=3:1) to give yellow oil 22-b (75 mg, yield 78%). LC-MS (ESI): m/z=402 [M+H].sup.+.

[0347] Synthesis of Compound 22-a

[0348] Under N.sub.2 atmosphere, compound 22-b (60 mg, 0.15 mmol), compound 22-c (120 mg, 0.23 mmol) and cesium carbonate (98 mg, 0.3 mmol) were suspended in dioxane (3 mL) and water (0.3 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (11 mg, 0.02 mmol) was added. The mixture was stirred at 100? C. for 12 hrs, cooled to room temperature, followed by adding water (10 mL), being extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica preparative plate (DCM: methanol=20:1) to give brown solid 22-a (43 mg, yield 70%).

[0349] Synthesis of Compound 22

[0350] At room temperature, 1M NaOH aq. solution (1 mL) was added to a solution of compound 22-a (43 mg, 0.1 mmol) in methanol (1 mL) and THF (1 mL). The mixture was stirred for 4 hrs, followed by evaporating under reduced pressure to remove methanol. The residue was adjusted to pH=5-6 with 1M HCl aq. solution, followed by being extracted with DCM (10 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica preparative plate (DCM: methanol=10:1) to give yellow solid 22 (21 mg, yield 53%). LC-MS (ESI): m/z=383 [M+H].sup.+.

[0351] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 9.21 (s, 1H), 8.38 (s, 1H), 7.98 (d, J=8.4 Hz, 1H), 7.95 (s, 2H), 7.78 (d, J=8.8 Hz, 1H), 7.73 (d, J=8.0 Hz, 1H), 7.63 (s, 1H), 7.50 (d, J=8.0 Hz, 1H), 1.61 (s, 6H) ppm.

Embodiment 23

2-{[4-(2-Chloro-4-cyanophenyl)isoquinolin-6-yl]thio}-2-methyl propionic acid (Compound 23)

[0352] ##STR00114##

[0353] Synthesis of Compound 23-b

[0354] Under N.sub.2 atmosphere, bis(pinacolato)diboron (391 mg, 1.54 mmol), potassium acetate (412 mg, 4.5 mmol) and [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (102 mg, 0.14 mmol) were respectively added to a solution of 2-chloro-4-bromobenzonitrile (300 mg, 1.4 mmol) in dioxane (15 mL). The mixture was stirred at 80? C. for 12 hrs, cooled to room temperature, filtered through celite, washed with EA (50 mL). The filtrate was evaporated under reduced pressure, and the residue was purified by silica preparative plate to give white solid 23-b (73 mg, yield 20%).

[0355] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 7.78 (d, J=7.6 Hz, 1H), 7.62 (d, J=1.2 Hz, 1H), 7.52 (dd, J=7.6 Hz, 1.2 Hz, 1H), 1.37 (s, 12H) ppm.

[0356] Synthesis of Compound 23-a

[0357] Under N.sub.2 atmosphere, compound 22-b (100 mg, 0.15 mmol), compound 23-b (73 mg, 0.27 mmol) and cesium carbonate (163 mg, 0.5 mmol) were suspended in dioxane (3 mL) and water (0.3 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (19 mg, 0.03 mmol) was added. The mixture was stirred at 100? C. for 12 hrs, cooled to room temperature, followed by adding water (10 mL), being extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica preparative plate (DCM: methanol=20:1) to give white solid 23-a (72 mg, yield 71%). LC-MS (ESI): m/z=411 [M+H].sup.+.

[0358] Synthesis of Compound 23

[0359] At room temperature, 1M NaOH aq. solution (1 mL) was added to a solution of compound 23-a (72 mg, 0.18 mmol) in methanol (1 mL) and THF (1 mL). The mixture was stirred for 2 hrs, followed by evaporating under reduced pressure to remove methanol. The residue was adjusted to pH=5-6 with 1M HCl aq. solution, followed by being extracted with DCM (10 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica preparative plate (DCM: methanol=10:1) to give white solid 23 (31 mg, yield 46%). LC-MS (ESI): m/z=383 [M+H].sup.+.

[0360] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.42 (s, 1H), 8.44 (s, 1H), 8.31 (d, J=1.6 Hz, 1H), 8.21 (d, J=8.4 Hz, 1H), 8.03 (dd, J=8.0 Hz, 1.2 Hz, 1H), 7.73 (d, J=8.0 Hz, 1H), 7.39 (s, 1H), 1.42 (s, 3H), 1.41 (s, 3H) ppm.

Embodiment 24

1-{[4-(4-cyanonaphthalen-1-yl)isoquinolin-6-yl]thio}cyclobutane-1-carboxylic acid (Compound 24)

[0361] ##STR00115##

[0362] Synthesis of Compound 24-a

[0363] Na.sub.2S.9H.sub.2O (182 mg, 0.75 mmol) was added to a solution of compound 5-b (180 mg, 0.5 mmol) in DMF (2 mL). The mixture was reacted in a microwave at 130? C. for 1 h, cooled to room temperature, 1-bromo-cyclobutanoic acid ethyl ester (155 mg, 0.75 mmol) was added, the mixture was stirred at 50? C. for 2 hrs. The mixture was cooled to room temperature, followed by adding ice water (20 mL), being extracted with EA (50 mL). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica preparative plate (PE:EA=1:1) to give white solid 24-a (89 mg, yield 40%). LC-MS (ESI): m/z=439 [M+H].sup.+.

[0364] Synthesis of Compound 24

[0365] At room temperature, LiOH.H.sub.2O (26 mg, 0.61 mmol) was added to a mixed solution of compound 24-a (89 mg, 0.20 mmol) in methanol (1 mL), THF (1 mL) and water (1 mL). The mixture was stirred for 4 hrs, concentrated under reduced pressure, followed by adding water (10 mL) and EA (20 mL). The aqueous phase was adjusted to pH=5-6 with 0.5M HCl aq. solution, solid turned out, the mixture was further stirred for 30 mins and filtered. The solid was washed with water (10 mL), dried under vacuum to give white solid 24 (65 mg, yield 78%). LC-MS (ESI): m/z=411 [M+H].sup.+.

[0366] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.69 (s, 1H), 9.41 (s, 1H), 8.52 (s, 1H), 8.33 (d, J=8.0 Hz, 1H), 8.31 (d, J=8.0 Hz, 1H), 8.19 (d, J=8.0 Hz, 1H), 7.83 (m, 1H), 7.69 (d, J=8.0 Hz, 1H), 7.57 (m, 1H), 7.51 (d, J=8.0 Hz, 1H), 7.39 (d, J=8.0 Hz, 1H), 2.51 (m, 1H), 2.01 (m, 3H), 1.71 (m, 2H) ppm.

Embodiment 25

3-{3-[(2, 6-dichlorophenyl)methyl]-1-methylimidazole[1,5-a]pyridine-6-yl}propionic acid (Compound 25)

[0367] ##STR00116##

[0368] Synthesis of Compound 25-e

[0369] At 0? C., a solution of 3M methyl magnesium bromide in THF (2.09 mL, 6.28 mmol) was added into a solution of 5-bromo-2-cyanopyridine (1.0 g, 5.46 mmol) in anhydrous THF (10 mL). The mixture was warmed to room temperature slowly, further stirred for 30 mins, and followed by adding methanol (20 mL), adding NaBH.sub.4 (410 mg, 10.93 mmol) in portions. The mixture was further stirred for 10 hrs, followed by adding water (10 mL) and 2M NaOH aq. solution (10 mL) in turn, being extracted with EA (50 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica preparative plate (PE:EA=1:1) to give white solid 25-e (1.0 g, yield 91%). LC-MS (ESI): m/z=201 [M+H].sup.+.

[0370] Synthesis of Compound 25-d

[0371] At room temperature, oxalyl chloride (0.69 g, 5.47 mmol) and DMF (0.1 mL) were added to a solution of 2,6-dichlorophenylacetic acid (1.02 g, 4.97 mmol) in DCM (10 mL), the mixture was stirred for 2 hrs and concentrated under reduced pressure. The residue was dissolved in DCM (10 mL) again, at 0? C., the above solution was slowly added to a solution of compound 25-e (1.0 g, 4.97 mmol) and triethyl amine (1.39 mL, 9.95 mmol) in DCM (10 mL). The mixture was warmed to room temperature and further stirred for 2 hrs, followed by adding water (20 mL), and being extracted with DCM (50 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified (PE:EA=5:1) to give light yellow solid 25-d (0.9 g, yield 46%). LC-MS (ESI): m/z=387 [M+H].sup.+.

[0372] Synthesis of Compound 25-c

[0373] Under N.sub.2 atmosphere, methyl acrylate (0.186 mL , 2.06 mmol), palladium acetate (23.1 mg, 0.1 mmol), tris(o-methylphenyl)phosphine (62.7 mg, 0.2 mmol) and triethyl amine (0.28 mL, 2 mmol) were added to a solution of compound 25-d (400 mg, 1.03 mmol) in DMF (5 mL). The mixture was reacted in a microwave at 120? C. for 10 mins, cooled to room temperature, followed by adding water (15 mL), being extracted with EA (30 mL?3). The organic phase was washed in turn with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 25-c (400 mg, yield 98%). LC-MS (ESI): m/z=393 [M+H].sup.+.

[0374] Synthesis of Compound 25-b

[0375] Under H.sub.2 atmosphere (1 atm.), the PdC (50 mg) was added to a solution of compound 25-c (400 mg, 1.02 mmol) in ethanol (10 mL). The mixture was stirred for 12 hrs, filtered, and concentrated under reduced pressure to give compound 25-b (350 mg, yield 87%). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=393 [M+H].sup.+.

[0376] Synthesis of Compound 25-a

[0377] Compound 25-b (350 mg, 0.89 mmol) was dissolved in phosphorus oxychloride (8 mL), stirred at 110? C. for 5 hrs. The mixture was cooled to room temperature, added to ice water (20 mL), followed by adding sodium carbonate solid to adjust pH=8, and then extracted with EA (30 mL?3). The organic phases were in turn washed with water (20 mL) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give yellow oil 25-a (150 mg, yield 45%). LC-MS (ESI): m/z=377 [M+H].sup.+.

[0378] Synthesis of Compound 25

[0379] At room temperature, 20% NaOH aq. solution (2 mL) was added to a solution of compound 25-a (120 mg, 0.32 mmol) in methanol (2 mL). The reaction solution was stirred for 2 hrs, concentrated under reduced pressure to remove methanol, 6M HCl aq. solution was added to adjust pH=7, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 25 (65 mg, yield 56%). LC-MS (ESI): m/z=363 [M+H].sup.+.

[0380] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 7.91 (s, 1H), 7.30-7.46 (m, 4H), 6.67 (d, J=9.6 Hz, 1H), 4.60 (s, 2H), 2.89 (t, J=7.6 Hz, 1H), 2.67 (t, J=7.6 Hz, 2H), 2.38 (s, 3H) ppm.

Embodiment 26

2-({1-[(2,6-dichlorophenyl)methyl]-3-methyl-1H-indazol-6-yl}thio)-2-methyl propionic acid (Compound 26)

[0381] ##STR00117##

[0382] Synthesis of Compound 26-b

[0383] At room temperature, potassium carbonate (490 mg, 3.55 mmol) was added to a solution of 6-bromo-3-methyl-1H-indazole (500 mg, 2.37 mmol) and 2,6-dichlorobenzyl bromide (680 mg, 2.84 mmol) in DMF (5 mL). The mixture was stirred for 12 hrs, followed by adding water (10 mL), being extracted with EA (20 mL?3). The organic phases were combined, washed in turn with water (10 mL) and saturated brine (10 mL), dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give yellow oil 26-b (400 mg, yield 45%). LC-MS (ESI): m/z=369 [M+H].sup.+.

[0384] Synthesis of Compound 26-a

[0385] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (25.5 mg, 0.02 mmol), 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (31 mg, 0.05 mmol) and CuI (5.1 mg, 0.02 mmol) were added to a solution of compound 26-b (100 mg, 0.27 mmol), ethyl 2-methyl-2-mercaptopropionate (0.04 mL, 0.27 mmol) and diisopropylethylamine (0.14 mL, 0.81 mmol) in dioxane (2 mL). The mixture was reacted in a microwave at 125? C. for 1 h, cooled to room temperature, concentrated under reduced pressure to remove dioxane. The residue was purified by silica preparative plate chromatography (PE:EA=1:1) to give compound 26-a (80 mg, yield 67%). LC-MS (ESI): m/z=437 [M+H].sup.+.

[0386] Synthesis of Compound 26

[0387] At room temperature, NaOH (72 mg, 1.8 mmol) was added to a mixed solution of compound 26-a (80 mg, 0.18 mmol) in methanol (2 mL), THF (2 mL) and water (2 mL).

[0388] The mixture was stirred for 2 hrs, adjusted to pH=7 by 2M HCl aq. solution, extracted with EA (20 mL?3). The organic phases were washed in turn with water (10 mL) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give compound 26 (20 mg, yield 27%). LC-MS (ESI): m/z=409 [M+H].sup.+.

[0389] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 7.60 (s, 1H), 7.52 (d, J=8.0 Hz, 1H), 7.34 (m, 2H), 7.24 (m, 1H), 7.13 (d, J=8.0 Hz, 1H), 5.64 (s, 1H), 2.37 (s, 3H), 1.35 (s, 6H) ppm.

Embodiment 27

2-{[5-(4-Cyanophenyl)imidazo[1,2-a]pyridin-6-yl]thio}-2-methyl propionic acid (Compound 27)

[0390] ##STR00118##

[0391] Synthesis of Compound 27-d

[0392] Under N.sub.2 atmosphere, 2-amino-6-bromopyridine (500 mg, 2.89 mmol), 4-cyanophenylboronic acid (510 mg, 3.47 mmol) and sodium carbonate (920 mg, 8.67 mmol) were suspended in DMF (10 mL) and water (5 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (240 mg, 0.29 mmol) was added. The mixture was stirred at 80? C. for 2 hrs, cooled to room temperature, followed by adding water (15 mL), being extracted with EA (30 mL?3). The organic phase was washed in turn with water (20 mL) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 27-d (400 mg, yield 71%). LC-MS (ESI): m/z=196 [M+H].sup.+.

[0393] Synthesis of Compound 27-c

[0394] At 0? C., N-bromosuccinimide (360 mg, 2.05 mmol) was added to a solution of compound 27-d (400 mg, 2.05 mmol) and ammonium acetate (160 mg, 2.05 mmol) in CH.sub.3CN (10 mL). The reaction solution was warmed to room temperature and stirred for 12 hrs, and concentrated under reduced pressure to remove solvent. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 27-c (500 mg, yield 89%). LC-MS (ESI): m/z=274 [M+H].sup.+.

[0395] Synthesis of Compound 27-b

[0396] A solution of sodium acetate (42 mg, 0.78 mmol) and 2-bromo-1,1-diethoxyethane (0.28 mL, 1.8 mmol) in conc. HCl aqueous solution (0.1 mL) and water (0.6 mL) was heated to 110? C. and refluxed for 10 mins. The reaction solution was cooled to 60? C., the solution was added to a solution of compound 27-b (250 mg, 0.91 mmol) and sodium acetate (83 mg, 1.55 mmol) in 60% ethanol aqueous solution (10 mL). The mixture was heated to 100? C. and refluxed for 2.5 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was added to ice water (5 mL), adjusted to pH=7 with saturated sodium bicarbonate solution, extracted with EA (30 mL?3). The organic phase was washed in turn with water (20 mL) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=1:1) to give compound 27-b (150 mg, yield 55%). LC-MS (ESI): m/z=298 [M+H].sup.+.

[0397] Synthesis of Compound 27-a

[0398] Na2S.9H.sub.2O (182 mg, 0.75 mmol) was added to a solution of compound 27-b (180 mg, 0.5 mmol) in N-methyl pyrrolidone (2 mL). The reaction solution was reacted in a microwave at 150? C. for 1 h, cooled to room temperature, followed by adding ethyl 2-bromo-2-methylpropionate (100 mg, 0.67 mmol) and potassium carbonate (90 mg, 0.67 mmol). The mixture was stirred at 50? C. for 2 hrs, cooled to room temperature, followed by adding water (5 mL), being extracted with EA (10 mL). The organic phase was washed in turn with water (10 mL) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 27-a (10 mg, yield 8%). LC-MS (ESI): m/z=366 [M+H].sup.+.

[0399] Synthesis of Compound 27

[0400] At room temperature, LiOH (13.1 mg, 0.55 mmol) was added to a solution of compound 27-a (10 mg, 0.02 mmol) in methanol (2 mL), THF (2 mL) and water (4 mL). The mixture was stirred for 2 hrs, adjusted to pH=7 with 2M HCl aq. solution, extracted with EA (20 mL?3). The organic phase was in turn washed with water (10 mL) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give compound 27 (5 mg, yield 54%). LC-MS (ESI): m/z=338 [M+H].sup.+.

[0401] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 7.97 (d, J=8.0 Hz, 1H), 7.59-7.70 (m, 5H), 7.26 (s, 1H), 1.38 (s, 6H) ppm.

Embodiment 28

2-{[3-(4-Cyanophenyl)-[1,2,4]triazo[4,3-a]pyridin-6-yl]thio}-2-methyl propionic acid (Compound 28)

[0402] ##STR00119##

[0403] Synthesis of Compound 28-c

[0404] At room temperature, a mixture of 2-hydrazino-5-bromopyridine (1.0 g, 5.3 mmol), 4-cyanobenzoyl chloride (0.97 g, 5.85 mmol), triethyl amine (0.64 g, 0.88 mmol) and DCM (15 mL) was stirred for 12 hrs, and filtered. The solid was washed with DCM (5 mL), dried under vacuum to give yellow solid 28-c (1.13 g, yield 67%). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=319 [M+H].sup.+.

[0405] Synthesis of Compound 28-b

[0406] Compound 28-c (1.03 g, 3.25 mmol) was added to POCl.sub.3 (10 mL). The mixture was stirred at 100? C. for 12 hrs, cooled to room temperature, and concentrated under reduced pressure. Saturated NaHCO.sub.3 aq. solution was added to the residue to adjust pH=7, the mixture was extracted with EA (50 mL?2). The organic phase was in turn washed with water (30 mL) and saturated NaHCO.sub.3 aq. solution (30 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give compound 28-b (0.85 g, yield 80%). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=301 [M+H].sup.+.

[0407] Synthesis of Compound 28-a

[0408] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (54 mg , 0.05 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (68 mg , 0.11 mmol) were added to a solution of compound 28-b (350 mg, 1.17 mmol), ethyl 2-methyl-2-mercaptopropionate (208 mg, 1.4 mmol) and diisopropylethylamine (302 mg, 2.34 mmol) in dioxane (10 mL). The mixture was reacted in a microwave at 110? C. for 1 h, cooled to room temperature, concentrated under reduced pressure to remove dioxane. The residue was purified by silica preparative plate chromatography (PE:EA=3:1-1:1) to give compound 28-a (268 mg, yield 55%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0409] Synthesis of Compound 28

[0410] At room temperature, LiOH (51 mg, 1.22 mmol) was added to a solution of compound 28-a (223 mg, 0.61 mmol) in methanol (2 mL), THF (6 mL) and water (2 mL). The mixture was stirred for 3 hrs, concentrated under reduced pressure, followed by adding water (10 mL), being extracted with EA (30 mL?2), the aqueous phase was adjusted to pH=5-6 with 2M HCl aq. solution and extracted with EA (30 mL?2). The organic phases were combined, washed in turn with water (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was recrystallized in EA (15 mL) and PE (10 mL) to give yellow solid 28 (108 mg, yield 52%). LC-MS (ESI): m/z=339 [M+H].sup.+.

[0411] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.92 (s, 1H), 8.56 (s, 1H), 8.12 (m, 4H), 7.92 (d, J=9.8 Hz, 1H), 7.45 (d, J=9.4 Hz, 1H), 1.44 (s, 6H) ppm.

Embodiment 29

7-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridin-2-formic acid (Compound 29)

[0412] ##STR00120##

[0413] Synthesis of Compound 29-c

[0414] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (24 mL, 60 mmol) was slowly added to a solution of diisopropylamine (6.1 g, 60 mmol) in anhydrous THF (100 mL). The mixture was stirred for 15 mins, followed by adding a solution of 3-bromo-4-chloropyridine (9.6 g, 50 mmol) in anhydrous THF (100 mL), further stirred for 1 h, followed by adding anhydrous DMF (10 mL) and stirred for 30 mins. The mixture was slowly warmed to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (300 mL), the mixture was extracted with EA (300 mL?3). The organic phases were combined, washed in turn with water (100 mL) and saturated brine (100 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica preparative plate chromatography (PE:EA=2:1-1:1) to give light yellow solid 29-c (5.9 g, yield 54%).

[0415] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 10.44 (s, 1H), 8.80 (s, 1H), 7.67 (s, 1H) ppm.

[0416] Synthesis of Compound 29-b

[0417] Ethyl mercaptoacetate (2.4 g, 20 mmol) and potassium carbonate (3.0 g, 24 mmol) were added to a solution of compound 29-c (4.4 g, 20 mmol) in DMF (40 mL). The mixture was heated to 45? C. and stirred for 12 hrs, cooled to room temperature, followed by adding ice water (200 mL), solid was precipitated and filtered out. The solid was washed with water (100 mL?3) and dried under vacuum to give white solid 29-b (5.1 g, yield 89.5%). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=286 [M+H].sup.+.

[0418] Synthesis of Compound 29-a

[0419] Under N.sub.2 atmosphere, compound 29-b (285 mg, 1 mmol), compound 3-c (279 mg, 1 mmol) and sodium carbonate (212 mg, 2 mmol) were suspended in dioxane (6 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (73 mg, 0.1 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was purified by silica preparative plate (PE:EA=2:1) to give compound 29-a (190 mg, yield 53%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0420] Synthesis of Compound 29

[0421] At room temperature, LiOH (41 mg, 1 mmol) was added to a solution of compound 29-a (190 mg, 0.53 mmol) in methanol (3 mL), THF (3 mL) and water (3 mL). The mixture was stirred for 1 h, adjusted to pH=5-6 with 2M HCl aq. solution, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give light yellow solid 29 (130 mg, yield 74%). LC-MS (ESI): m/z=331 [M+H].sup.+.

[0422] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.42 (s, 1H), 8.64 (s, 1H), 8.40 (s, 1H), 8.35 (d, J=8.0 Hz, 1H), 8.29 (d, J=8.0 Hz, 1H), 7.90 (m, 2H), 7.66 (s, 2H) ppm.

Embodiment 30

3-[7-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridin-2-yl]propionic acid (Compound 30)

[0423] ##STR00121##

[0424] Synthesis of Compound 30-d

[0425] At ?78? C., a solution of 1.0M diisobutylaluminum hydride in DCM (58 mL, 58 mmol) was slowly added to a solution of compound 29-b (5.7 g, 20 mmol) in DCM (50 mL). The mixture was stirred for 1 h, warmed to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (300 mL). The organic phase was seperated, the aqueous phase was extracted with DCM (50 mL?3). The organic phases were combined, washed in turn with water (50 mL) and saturated brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give light yellow solid 30-d (4 g, yield 83%). LC-MS (ESI): m/z=242 [M+H].sup.+.

[0426] Synthesis of Compound 30-c

[0427] At 0? C., triethyl phosphonoacetate (2.82 mL, 10 mmol) and sodium hydride (0.48 g, 12 mmol) were respectively added to a solution of compound 30-d (2.42 g, 10 mmol) in THF (50 mL). The mixture was further stirred for 1 h, warmed to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (300 mL), the mixture was extracted with EA (50 mL?3). The organic phases were combined, washed in turn with water (30 mL?3) and saturated brine (30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give light yellow solid 30-c (2 g, yield 64%). LC-MS (ESI): m/z=312 [M+H].sup.+.

[0428] Synthesis of Compound 30-b

[0429] At 0? C., NaBH.sub.4 (0.25 g, 6.4 mmol) was slowly added to a solution of compound 30-c (2.0 g, 6.4 mmol) and NiCl (0.82 g, 6.4 mmol) in methanol (50 mL). The mixture was stirred for 3 hrs, warmed to room temperature, followed by adding NH.sub.4Cl aq. solution (300 mL), the mixture was extracted with EA (100 mL?3). The organic phases were combined, washed in turn with water (50 mL?3) and saturated brine (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=4:1) to give light yellow solid 30-b (1.6 g, yield 80%). LC-MS (ESI): m/z=314 [M+H].sup.+.

[0430] Synthesis of Compound 30-a

[0431] Under N.sub.2 atmosphere, compound 30-b (155 mg, 0.5 mmol), compound 3-c (140 mg, 0.5 mmol) and sodium carbonate (106 mg, 1 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 30-b (120 mg, yield 62%). LC-MS (ESI): m/z=387 [M+H].sup.+.

[0432] Synthesis of Compound 30

[0433] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 30-a (120 mg, 0.31 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, adjusted to pH=5-6 by 2M HCl aq. solution, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 30 (93 mg, yield 84%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0434] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.15 (s, 1H), 8.42 (s, 1H), 8.32 (d, J=8.0 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.90 (m, 1H), 7.81 (m, 1H), 7.68 (m, 2H), 3.10 (t, J=8.0 Hz, 2H), 3.07 (d, J=8.0 Hz, 2H) ppm.

Embodiment 31

2-[7-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridin-2-yl]acetic acid (Compound 31)

[0435] ##STR00122##

[0436] Synthesis of Compound 31-b

[0437] NaOH (40 mg, 1 mmol) was added to a solution of methyl(methylthiomethyl)sulfoxide (18 mg, 1.5 mmol) and compound 30-d (240 mg, 1 mmol) in THF (6 mL). The mixture was heated to 80? C. and stirred for 4 hrs, cooled to room temperature, concentrated under reduced pressure to remove the solvent. The residue was added to a solution of 2M HCl in methanol (10 mL), refluxed for 1 h, concentrated under reduced pressure. The residue was added to saturated NaHCO.sub.3 aq. solution (10 mL), extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (10 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=4:1) to give compound 31-b (0.15 g, yield 88%). LC-MS (ESI): m/z=285 [M+H].sup.+.

[0438] Synthesis of Compound 31-a

[0439] Under N.sub.2 atmosphere, compound 31-b (87 mg, 0.3 mmol), compound 3-c (84 mg, 0.3 mmol) and sodium carbonate (60 mg, 0.6 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (25 mg, 0.03 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was washed in turn with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 31-a (76 mg, yield 71%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0440] Synthesis of Compound 31

[0441] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 31-a (120 mg, 0.31 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 2M HCl aq. solution to adjust pH=5-6, solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 31 (44 mg, yield 64%). LC-MS (ESI): m/z=345 [M+H].sup.+.

[0442] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.30 (s, 1H), 8.55 (s, 1H), 8.36 (d, J=7.6 Hz, 1H), 8.29 (d, J=7.6 Hz, 1H), 7.90 (m, 2H), 7.72 (m, 3H), 4.04 (s, 2H) ppm.

Embodiment 32

2-[7-(4-Cyanophenyl)thieno[3,2-c]pyridin-2-yl]acetic acid (Compound 32)

[0443] ##STR00123##

[0444] Synthesis of Compound 32-a

[0445] Under N.sub.2 atmosphere, compound 31-b (140 mg, 0.5 mmol), 4-cyanophenyl boronic acid (75 mg, 0.5 mmol) and sodium carbonate (60 mg, 0.6 mmol) were suspended in dioxane (4 mL) and water (10 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (25 mg, 0.03 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 32-b (86 mg, yield 56%). LC-MS (ESI): m/z=309 [M+H].sup.+.

[0446] Synthesis of Compound 32

[0447] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 32-a (86 mg, 0.28 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 2M HCl aq. solution (2 mL), solid was precipitated and filtered out. The solid was washed with water (10 mL), dried under vacuum to give white solid 32 (28 mg, yield 34%). LC-MS (ESI): m/z=295 [M+H].sup.+.

[0448] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.87 (s, 1H), 9.11 (s, 1H), 8.64 (s, 1H), 8.06 (d, J=7.6 Hz, 1H), 7.91 (d, J=7.6 Hz, 1H), 7.57 (s, 1H), 4.06 (s, 2H) ppm.

Embodiment 33

3-[7-(4-Cyanophenyl)thieno[3,2-c]pyridin-2-yl]-2,2-dimethylpropionic acid (Compound 33)

[0449] ##STR00124##

[0450] Synthesis of Compound 33-b

[0451] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (2.0 mL, 5 mmol) was slowly added to a solution of diisopropylamine (505 mg, 5 mmol) in anhydrous THF (10 mL). The mixture was stirred for 15 mins, added dropwise to a solution of compound 30-b (630 mg, 2 mmol) in anhydrous THF (10 mL), stirred for 2 hrs, followed by adding CH.sub.3I (720 mg, 5 mmol) and the mixture was further stirred for 3 hrs. The mixture was slowly warmed to room temperature, then added to saturated NH.sub.4Cl aq. solution (30 mL), extracted with EA (30 mL?3). The organic phases were combined, washed in turn with water (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica preparative plate chromatography (PE:EA=2:1-1:1) to give light yellow liquid 33-b (310 mg, yield 45%).

[0452] Synthesis of Compound 33-a

[0453] Under N.sub.2 atmosphere, compound 33-b (310 mg, 0.91 mmol), 4-cyanophenyl boronic acid (140 mg, 0.91 mmol) and sodium carbonate (212 mg, 2 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, and then cooled to room temperature, concentrated under reduced pressure to remove the solvent. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give yellow liquid 33-a (76 mg, yield 23%). LC-MS (ESI): m/z=365 [M+H].sup.+.

[0454] Synthesis of Compound 33

[0455] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 33-a (73 mg, 0.19 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 2M HCl aq. solution (2 mL) and water (1 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 33 (39 mg, yield 61%). LC-MS (ESI): m/z=337 [M+H].sup.+.

[0456] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.34 (s, 1H), 8.64 (s, 1H), 8.02 (s, 4H), 7.71 (s, 1H), 7.57 (s, 1H), 3.34 (s, 2H), 1.26 (s, 6H) ppm.

Embodiment 34

3-[7-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridin-2-yl]-2,2-dimethylpropionic acid (Compound 34)

[0457] ##STR00125##

[0458] Synthesis of Compound 34-a

[0459] Under N.sub.2 atmosphere, compound 33-b (230 mg, 0.7 mmol), compound 3-c (280 mg, 0.5 mmol) and sodium carbonate (150 mg, 1.4 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was prepared by HPLC (mobile phase: 10 mM NH.sub.4HCO.sub.3 aq. solution: acetonitrile =35%-45%) to give compound 34-a (53 mg, yield 18%). LC-MS (ESI): m/z=401 [M+H].sup.+.

[0460] Synthesis of Compound 34

[0461] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 34-a (41 mg, 0.1 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 2M HCl aq. solution (2 mL) and water (1 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 34 (16 mg, yield 41%). LC-MS (ESI): m/z=387 [M+H].sup.+.

[0462] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.41 (s, 1H), 9.19 (s, 1H), 8.43 (s, 1H), 8.32 (d, J=7.6 Hz, 1H), 8.27 (d, J=7.6 Hz, 1H), 7.88 (m, 2H), 7.65 (m, 2H), 7.47 (s, 1H), 3.14 (s, 2H), 1.12 (s, 6H) ppm.

Embodiment 35

3-{7-[(2,6-Dichlorophenyl)methyl]-1-benzothiophene-2-yl}propionic acid (Compound 35)

[0463] ##STR00126##

[0464] Synthesis of Compound 35-b

[0465] At 0? C., triethyl amine (3.6 mL) was slowly added to a mixture of n-butanol (10 mL) and formic acid (1 mL). The mixture was stirred for 10 mins, followed by adding 7-bromo-1-benzothiophene-2-carbaldehyde (241 mg, 1 mmol) and 2,2-dimethyl-1,3-dioxane-4,6-dione (216 mg, 1.5 mmol). The mixture was heated to reflux for 8 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=15:1) to give compound 35-b (200 mg, yield 59%). LC-MS (ESI): m/z=341 [M+H].sup.+.

[0466] Synthesis of Compound 35-a

[0467] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (54 mg, 0.05 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (94 mg, 0.02 mmol) and a solution of 0.4M 2,6-dichlorobenzyl zinc bromide in THF solution (2.5 mL, 1 mmol) were added to a solution of compound 35-b (170 mg, 0.5 mmol) in anhydrous THF (10 mL). The mixture was reacted at 60? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 35-a (170 mg, yield 80%). LC-MS (ESI): m/z=421 [M+H].sup.+.

[0468] Synthesis of Compound 35

[0469] At room temperature, 1.0M NaOH aq. solution (3 mL) was added to a solution of compound 35-a (84 mg, 0.2 mmol) in methanol (4 mL) and THF (8 mL). The mixture was stirred for 16 hrs, and concentrated under reduced pressure. The residue was adjusted to pH=3 with 1M HCl aq. solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 35 (60 mg, yield 82%). LC-MS (ESI): m/z=365 [M+H].sup.+.

[0470] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.35 (s, br. 1H), 7.61 (d, J=8.0 Hz, 1H), 7.58 (d, J=8.0 Hz, 2H), 7.42 (t, J=8.0 Hz, 1H), 7.25 (s, 1H), 7.21 (t, J=8.0 Hz, 1H), 6.47 (d, J=7.2 Hz, 1H), 4.35 (s, 2H), 3.16 (t, J=7.2 Hz, 2H), 2.71 (t, J=7.2 Hz, 2H) ppm.

Embodiment 36

{3-4-[(2,6-Dichlorophenyl)methyl]-1-benzothiophene-2-yl}propionic acid (Compound 36)

[0471] ##STR00127##

[0472] Synthesis of Compound 36-b

[0473] At 0? C., triethyl amine (3.6 mL) was slowly added to a mixture of n-butanol (10 mL) and formic acid (1 mL). The mixture was stirred for 10 mins, followed by adding 4-bromo-1-benzothiophene-2-carbaldehyde (241 mg, 1 mmol) and 2,2-dimethyl-1,3-dioxane-4,6-dione (216 mg, 1.5 mmol). The mixture was heated to reflux for 8 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=15:1) to give compound 36-b (221 mg, yield 65%). LC-MS (ESI): m/z=341 [M+H].sup.+.

[0474] Synthesis of Compound 36-a

[0475] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (47 mg, 0.05 mmol) and 2-dicyclohexylphospho-2,6-diisopropoxy-1,1-biphenyl (94 mg, 0.02 mmol) and a solution of 0.4M 2,6-dichlorobenzyl zinc bromide in THF solution (2.5 mL, 1 mmol) were added to a solution of compound 36-b (170 mg, 0.5 mmol) in anhydrous THF (10 mL). The mixture was reacted at 60? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 36-a (180 mg, yield 86%). LC-MS (ESI): m/z=421 [M+H].sup.+.

[0476] Synthesis of Compound 36

[0477] At room temperature, a solution of 1.0M NaOH aq. solution (3 mL) was added to a solution of compound 36-a (84 mg, 0.2 mmol) in methanol (4 mL) and THF (8 mL). The mixture was stirred for 16 hrs, and concentrated under reduced pressure. The residue was adjusted to pH=3 with 1M HCl aq. solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 36 (70 mg, yield 95%). LC-MS (ESI): m/z=365 [M+H].sup.+.

[0478] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.30 (s, br. 1H), 7.73 (d, J=8.0 Hz, 1H), 7.57 (d, J=8.0 Hz, 2H), 7.51 (s, 1H), 7.41 (t, J=8.0 Hz, 1H), 7.13 (t, J=8.0 Hz, 1H), 6.41 (d, J=7.2 Hz, 1H), 4.54 (s, 2H), 3.18 (t, J=7.2 Hz, 2H), 2.72 (t, J=7.2 Hz, 2H) ppm.

Embodiment 37

3-[4-[(4-Cyanonaphthalen-1-yl)thieno[2,3-c]pyridine-2-yl]propionic acid (Compound 37)

[0479] ##STR00128##

[0480] Synthesis of Compound 37-e

[0481] Ethyl mercaptoacetate (1.81 g, 15.1 mmol) and cesium carbonate (6.0 g, 18.6 mmol) were added to a solution of 3,5-dibromo-4-pyridinecarboxaldehyde (4.0 g, 15.1 mmol) in THF (100 mL). The mixture was stirred at 60? C. for 3 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=15:1) to give compound 37-e (3.7 g, yield 85%). LC-MS (ESI): m/z=286 [M+H].sup.+.

[0482] Synthesis of Compound 37-d

[0483] At 0? C., NaBH.sub.4 (530 mg, 13.9 mmol) was added into a solution of compound 37-e (1.0 g, 3.48 mmol), LiCl (590 mg, 13.9 mmol) in THF (40 mL) and methanol (20 mL). The mixture was warmed to room temperature and stirred for 4 hrs, concentrated under reduced pressure. Water (40 mL) and DCM (40 mL) were added to the residue, the organic phase was seperated, aqueous phase was extracted with DCM (20 mL?3). The organic phases were combined, washed in turn with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give compound 37-d (750 mg, yield 89%). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=244 [M+H].sup.+.

[0484] Synthesis of Compound 37-c

[0485] At 0? C., (1,1,1-triacetoxy)-1,1-dihydro-1,2-benzoiodooxol-3(1H)-one (1.39 g, 3.27 mmol) was added to a solution of compound 37-d (750 mg, 2.18 mmol) in DCM (30 mL). The reaction solution was warmed to room temperature and further stirred for 2 hrs, followed by adding saturated sodium bicarbonate aq. solution (10 mL) and saturated sodium thiosulfate aq. solution (10 mL). The mixture was stirred for 10 mins, organic phase was seperated. The organic phase was in turn washed with water (20 mL?3) and saturated brine (20 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 37-c (680 mg, yield 91%). LC-MS (ESI): m/z=342 [M+H].sup.+.

[0486] Synthesis of Compound 37-b

[0487] At 0? C., triethyl amine (3.6 mL) was slowly added to a mixture of n-butanol (10 mL) and formic acid (1 mL). The mixture was stirred for 10 mins, followed by adding compound 37-c (300 mg, 1.24 mmol) and 2,2-dimethyl-1,3-dioxane-4,6-dione (300 mg, 2.08 mmol), refluxing for 8 hrs. The mixture was cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=12:1) to give compound 37-b (280 mg, yield 66%). LC-MS (ESI): m/z=342 [M+H].sup.+.

[0488] Synthesis of Compound 37-a

[0489] Under N.sub.2 atmosphere, compound 37-b (120 mg, 0.35 mmol), compound 3-c (110 mg, 0.39 mmol) and sodium carbonate (150 mg, 1.4 mmol) were suspended in ethylene glycol dimethyl ether (10 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (40 mg, 0.05 mmol) was added. The mixture was stirred at 75? C. for 16 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=8:1) to give compound 37-a (90 mg, yield 62%). LC-MS (ESI): m/z=415 [M+H].sup.+.

[0490] Synthesis of Compound 37

[0491] At room temperature, a solution of 1.0M LiOH aq. solution (2 mL) was added to a solution of compound 37-a (100 mg, 0.25 mmol) in methanol (10 mL) and THF (10 mL). The mixture was stirred for 16 hrs, concentrated under reduced pressure. The residue was dissolved in water (10 mL), adjusted to pH=3 with 1M citric acid aq. solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 37 (50 mg, yield 55%). LC-MS (ESI): m/z=359 [M+H].sup.+.

[0492] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.30 (s, br. 1H), 9.30 (s, 1H), 8.44 (s, 1H), 8.32 (d, J=8.0 Hz, 1H), 8.26 (d, J=8.0 Hz, 1H), 7.87 (t, J=8.8 Hz, 1H), 7.73 (d, J=7.2 Hz, 1H), 7.68 (t, J=7.2 Hz, 1H), 7.57 (d, J=8.8 Hz, 1H), 6.74 (s, 1H), 3.10 (t, J=7.2 Hz, 2H), 2.59 (t, J=7.2 Hz, 2H) ppm.

Embodiment 38

3-[4-(4-Cyanonaphthalen-1-yl)-1-benzothiophen-2-yl]-2,2-dimethyl propionic acid (Compound 38)

[0493] ##STR00129##

[0494] Synthesis of Compound 38-c

[0495] At ?78? C., a solution of 1M lithium diisopropylamide in THF (3 mL, 3 mmol) was added slowly to a solution of methyl isobutyrate (714 mg, 7.1 mmol) in anhydrous THF (5 mL). The mixture was stirred for 1 h, followed by adding 4-bromo-1-benzothiophene-2-carbaldehyde (500 mg, 2.38 mmol). The mixture was slowly warmed to room temperature, followed by adding NH.sub.4Cl aq. solution (20 mL), being extracted with EA (30 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 38-c (700 mg, yield 86%). LC-MS (ESI): m/z=365 [M+Na].sup.+.

[0496] Synthesis of Compound 38-b

[0497] At 0? C., trifluoroacetic acid (2 mL) was added to a solution of compound 38-c (170 mg, 0.5 mmol) and triethylsilane (392 mg, 4 mmol) in DCM (10 mL). The mixture was warmed to room temperature and further stirred for 16 hrs, and then concentrated under reduced pressure. DCM (30 mL) was added to the residue. The mixture was in turn washed with saturated sodium bicarbonate solution (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 38-b (150 mg, yield 92%). LC-MS (ESI): m/z=349 [M+Na].sup.+.

[0498] Synthesis of Compound 38-a

[0499] Under N.sub.2 atmosphere, compound 38-b (150 mg, 0.46 mmol), compound 3-c (150 mg, 0.54 mmol) and sodium carbonate (300 mg, 2.8 mmol) were suspended in ethylene glycol dimethyl ether (12 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (50 mg, 0.06 mmol) was added. The mixture was stirred at 75? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by column chromatography (PE:EA=4:1) to give compound 38-a (105 mg, yield 57%). LC-MS (ESI): m/z=400 [M+H].sup.+.

[0500] Synthesis of Compound 38

[0501] At room temperature, 1.0M LiOH aq. solution (2.5 mL) was added to a solution of compound 38-a (100 mg, 0.25 mmol) in methanol (10 mL) and THF (10 mL). The mixture was stirred for 16 hrs, concentrated under reduced pressure. Water (10 mL) was added to the residue. The mixture was adjusted to pH=3 with 1M citric acid aq. solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 37 (80 mg, yield 83%). LC-MS (ESI): m/z=408 [M+Na].sup.+.

[0502] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.37 (s, br. 1H), 8.29 (d, J=8.0 Hz, 1H), 8.24 (d, J=8.0 Hz, 1H), 8.06 (d, J=8.0 Hz, 1H), 7.85 (t, J=8.0 Hz, 1H), 7.67 (d, J=8.0 Hz, 1H), 7.58-7.62 (m, 2H), 7.49 (t, J=7.2 Hz, 2H), 7.36 (d, J=7.2 Hz, 1H), 2.99 (s, 2H), 1.06 (s, 6H) ppm.

Embodiment 39

3-[4-(4-Cyanonaphthalen-1-yl)-1-benzothiophen-2-yl]-2,2-difluoro-3-hydroxyl propionic acid (Compound 39)

[0503] ##STR00130##

[0504] Synthesis of Compound 39-a

[0505] Under N.sub.2 atmosphere, Zn powder (130 mg, 2 mmol) was added to a solution of 4-bromo-1-benzothiophene-2-carbaldehyde (500 mg, 2.38 mmol) and ethyl difluorobromoacetate (808 mg, 4 mmol) in anhydrous THF (10 mL). The mixture was heated to 45? C. and further stirred for 16 hrs, cooled to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (20 mL), being extracted with EA (30 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 39-a (253 mg, yield 71%). LC-MS (ESI): m/z=388 [M+Na].sup.+.

[0506] Synthesis of Compound 39

[0507] Under N.sub.2 atmosphere, compound 39-a (190 mg, 0.5 mmol), compound 3-c (140 mg, 0.5 mmol) and sodium carbonate (106 mg, 1 mmol) were suspended in ethylene glycol dimethyl ether (20 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocenel palladium dichloride (50 mg, 0.06 mmol) was added. The mixture was stirred at 75? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. Water (20 mL) was added to the residue, the mixture was extracted with EA (30 mL?3). The aqueous phase was adjusted to pH=3 with 1M HCl aqueous solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 39 (120 mg, yield 58%). LC-MS (ESI): m/z=432 [M+Na].sup.+.

[0508] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 8.30 (d, J=7.2 Hz, 1H), 8.25 (d, J=8.0 Hz, 1H), 8.14 (d, J=8.0 Hz, 1H), 7.85 (t, J=7.0 Hz, 1H), 7.65-7.68 (m, 1H), 7.60-7.63 (m, 1H), 7.55 (t, J=8.0 Hz, 2H), 7.39-7.42 (m, 1H), 6.82 (d, J=16.8 Hz, 1H), 5.23-5.30 (m, 1H) ppm.

Embodiment 40

3-{4-[(2,6-Dichlorophenyl)methyl]-1-benzothiophen-2-yl]-2,2-dimethyl propionic acid (Compound 40)

[0509] ##STR00131##

[0510] Synthesis of Compound 40-a

[0511] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (47 mg, 0.05 mmol) and 2-dicyclohexylphospho-2,6-diisopropoxy-1,1-biphenyl (94 mg, 0.02 mmol) and a solution of 0.4M 2,6-dichlorobenzyl zinc bromide in THF solution (2.5 mL, 1 mmol) were added to a solution of compound 38-b (130 mg, 0.4 mmol) in anhydrous THF (10 mL). The mixture was reacted at 60? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=8:1) to give compound 40-a (150 mg, yield 72%). LC-MS (ESI): m/z=407 [M+H].sup.+.

[0512] Synthesis of Compound 40

[0513] At room temperature, 1.0M NaOH aq. solution (1 mL) was added to a solution of compound 40-a (84 mg, 0.2 mmol) in methanol (5 mL) and THF (5 mL). The mixture was stirred for 16 hrs, concentrated under reduced pressure. Water (10 mL) was added to the residue, 1M HCl aq. solution was added to adjust pH=3, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 40 (40 mg, yield 50%). LC-MS (ESI): m/z=393 [M+H].sup.+.

[0514] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.49 (s, br. 1H), 7.73(d, J=8.0 Hz, 1H), 7.56 (d, J=8.0 Hz, 1H), 7.45 (s, 1H), 7.41 (t, J=8.0 Hz, 2H), 6.45 (d, J=10.4 Hz, 1H), 4.54 (s, 2H), 3.16 (s, 3H), 1.20 (s, 6H) ppm.

Embodiment 41

3-[4-(4-Cyanonaphthalen-1-yl)thieno[2,3-c]pyridin-2-yl]-3-hydroxyl butyric acid (Compound 41)

[0515] ##STR00132##

[0516] Synthesis of Compound 41-e

[0517] At room temperature, 7.0M NaOH aq. solution (2 mL) was added to a solution of compound 37-e (1.0 g, 3.5 mmol) in methanol (4 mL) and THF (10 mL). The mixture was stirred for 2 hrs, concentrated under reduced pressure. Water (30 mL) was added to the residue, 1M citric acid aq. solution was added to adjust pH=3, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 41-e (740 mg, yield 82%).

[0518] Synthesis of Compound 41-d

[0519] At room temperature, N,O-dimethylhydroxylamine hydrochloride (546 mg, 5.6 mmol), 1-(3-dimethylaminopropyl)-3 -ethylcarbodiimide hydrochloride (1.08 g, 5.6 mmol), 1-hydroxybenzotriazole (378 mg, 2.8 mmol) and triethyl amine (1.13 g, 11.2 mmol) were added to a solution of compound 41-e (720 mg, 2.8 mmol) in DMF (10 mL) and DCM (30 mL). The mixture was stirred for 24 hrs, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 41-d (740 mg, yield 82%). LC-MS (ESI): m/z=301 [M+H].sup.+.

[0520] Synthesis of Compound 41-c

[0521] At ?78? C., 3M methyl magnesium bromide in ether (1 mL, 3 mmol) was added to a solution of compound 41-d (604 mg, 2 mmol) in anhydrous THF (20 mL). The mixture was slowly warmed to room temperature and further stirred for 20 mins, followed by adding saturated NH.sub.4Cl aq. solution (5 mL), water (20 mL) and EA (30 mL) in turn. The organic phase was seperated, the aqueous phase was extracted with EA (20 mL?2). The organic phases were combined, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=8:1) to give compound 41-c (740 mg, yield 82%). LC-MS (ESI): m/z=256 [M+H].sup.+.

[0522] Synthesis of Compound 41-b

[0523] Under N.sub.2 atmosphere, Zn powder (65 mg, 1 mmol) was added to a solution of compound 41-c (257 mg, 1 mmol) and ethyl bromoacetate (217 mg, 1.3 mmol) in anhydrous THF (10 mL). The mixture was heated to 50? C. and further stirred for 16 hrs, cooled to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (5 mL) and water (20 mL) in turn. The mixture was extracted with EA (30 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=4:1) to give compound 41-b (281 mg, yield 82%). LC-MS (ESI): m/z=344 [M+H].sup.+.

[0524] Synthesis of Compound 41-a

[0525] Under N.sub.2 atmosphere, compound 41-b (137 mg, 1 mmol), compound 3-c (140 mg, 0.5 mmol) and sodium carbonate (106 mg, 1 mmol) were suspended in ethylene glycol dimethyl ether (15 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene] palladium dichloride (50 mg, 0.06 mmol) was added. The mixture was stirred at 75? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 41-a (160 mg, yield 96%). LC-MS (ESI): m/z=417 [M+H].sup.+.

[0526] Synthesis of Compound 41

[0527] At room temperature, 1.0M LiOH aq. solution (5 mL) was added to a solution of compound 41-a (42 mg, 0.1 mmol) in methanol (5 mL) and THF (5 mL). The mixture was stirred for 16 hrs, concentrated under reduced pressure. Water (10 mL) was added to the residue, 1M citric acid aq. solution was added to adjust pH=3, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 41 (30 mg, yield 77%). LC-MS (ESI): m/z=389 [M+H].sup.+.

[0528] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.08 (s, br. 1H), 9.31 (s, 1H), 8.44 (s, 1H), 8.32 (d, J=7.2 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.87 (t, J=8.0 Hz, 1H), 7.73 (t, J=7.2 Hz, 1H), 7.62-7.67 (m, 1H), 7.59 (d, J=8.0 Hz, 1H), 6.79 (d, J=10.0 Hz, 1H), 2.65-2.76 (m, 2H), 1.56 (d, J=6.0 Hz, 3H) ppm.

Embodiment 42

3-[4-(4-Cyanonaphthalen-1-yl)thieno[2,3-c]pyridin-2-yl]butyric acid (Compound 42)

[0529] ##STR00133##

[0530] Synthesis of Compound 42-b

[0531] At 20? C., thionyl chloride (2 mL) was added to a solution of compound 41-a (160 mg, 0.4 mmol) in DCM (10 mL). The mixture was stirred for 16 hrs, concentrated under reduced pressure to give compound 42-b. The product was used directly for the next step without further purification.

[0532] Synthesis of Compound 42-a

[0533] At 0? C., NaBH.sub.4 (114 mg, 3 mmol) was added to a solution of compound 42-b, 10% PdC (30 mg) and ethanol (10 mL) in portions. The mixture was warmed to room temperature and stirred for 16 hrs, filtered through celite. Water (10 mL) was added to the filtrate, the mixture was extracted with DCM (10 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give compound 42-a (62 mg, yield 42%). LC-MS (ESI): m/z=401[M+H].sup.+.

[0534] Synthesis of Compound 42

[0535] At room temperature, 1M LiOH aq. solution (5 mL) was added to a solution of compound 42-a (40 mg, 0.1 mmol) in methanol (5 mL) and THF (5 mL). The mixture was stirred for 16 hrs, and concentrated under reduced pressure. Water (10 mL) was added to the residue, 1M citric acid aq. solution was added to adjust pH=3, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 42 (20 mg, yield 53%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0536] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 9.12 (s, 1H), 8.43 (s, 1H), 8.36 (d, J=8.8 Hz, 1H), 8.01 (t, J=8.0 Hz, 1H), 7.69-7.74 (m, 1H), 7.61 (d, J=8.8 Hz, 1H), 7.47-7.55 (m, 2H), 6.67 (d, J=4.4 Hz, 1H), 3.59-3.64 (m, 1H), 2.58-2.74 (m, 2H), 1.24 (d, J=9.0 Hz, 3H) ppm.

Embodiment 43

[0537] ##STR00134##

[0538] Synthesis of Compound 43A

[0539] Compound 42-a (170 mg) underwent enantiomeric chromatographic column (process II, mobile phase: n-Hexane (0.1% DEA): EtOH (0.1% DEA)=80:20), compound 43A-a (59 mg) (T.sub.r=18.0 min) was eluted firstly and compound 43B-a (46 mg) (T.sub.r=20.0 min) was eluted later, the absolute configuration of 43A-a and 43B-a remains unknown. At room temperature, 1M LiOH aq. solution (2.5 mL) was added to a solution of 43A-a (59 mg, 0.14 mmol) in methanol (5 mL). The mixture was stirred for 4 hrs, concentrated under reduced pressure to remove the solvent. Water (10 mL) was added to the residue, 1M citric acid aq. solution was added to adjust pH=6, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 43A (38 mg, yield 69%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0540] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.20 (s, 1H), 9.31 (s, 1H), 8.43 (s, 1H), 8.45 (s, 1H), 8.30 (dd, J=20.3 Hz, 7.9 Hz, 1H), 7.87 (t, J=7.4 Hz, 1H), 7.81-7.52 (m, 3H), 6.67 (d, J=5.7 Hz, 1H), 3.50 (dd, J=13.4 Hz, 6.4 Hz, 1H), 2.57 (dd, J=9.7 Hz, 6.30 Hz, 1H), 1.28 (d, J=9.0 Hz, 3H) ppm.

[0541] Synthesis of Compound 43B

[0542] At room temperature, 1M LiOH aq. solution (2.5 mL) was added to a solution of 43B-a (46 mg, 0.11 mmol) in methanol (5 mL). The mixture was stirred for 4 hrs, concentrated under reduced pressure to remove the solvent. Water (10 mL) was added to the residue, 1M citric acid aq. solution was added to adjust pH=6, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 43B (25 mg, yield 58%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0543] .sup.1H-NMR (400 MHz, CD.sub.3OD) ?: 9.19 (s, 1H), 8.47-8.28 (m, 2H), 8.18 (d, J=7.4 Hz, 1H), 7.93-7.78 (m, 1H), 7.70 (d, J=7.4 Hz, 1H), 7.63 (t, J=3.7 Hz, 1H), 6.75 (d, J=8.6 Hz, 1H), 3.61 (dd, J=13.6 Hz, 6.9 Hz, 1H), 2.73-2.56 (m, 2H), 1.40 (d, J=9.0 Hz, 3H) ppm.

Embodiment 44

[0544] ##STR00135## ##STR00136##

[0545] Synthesis of Compound 44-f

[0546] At room temperature, LiOH (1.68 g, 40 mmol) was added to a solution of compound 29-b (5.7 g, 20 mmol) in methanol (10 mL), THF (40 mL) and water (10 mL). The mixture was stirred for 1 h, followed by adding 2M HCl (20 mL) and water (20 mL), solid was precipitated and filtered out. The solid was washed with water (50 mL), dried under vacuum to give compound 44-f (4.5 g, yield 100%). LC-MS (ESI): m/z=258 [M+H].sup.+.

[0547] Synthesis of Compound 44-e

[0548] At room temperature, N,O-dimethylhydroxylamine hydrochloride (1.6 g, 3 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (5.6 g, 3 mmol), 1-hydroxybenzotriazole (4.04 g, 3 mmol) and diisopropylethylamine (3.9 g, 3 mmol) were added to a solution of compound 44-f (4.9 g, 3 mmol) in DCM (100 mL). The mixture was stirred for 8 hrs, followed by adding 2M HCl (50 mL) and water (20 mL), being extracted with DCM (80 mL?3). The organic phases were combined, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give compound 44-e (6 g, yield 100%). LC-MS (ESI): m/z=301 [M+H].sup.+.

[0549] Synthesis of Compound 44-d

[0550] At ?78? C., a solution of 1.5M methyl magnesium bromide in ether (20 mL, 30 mmol) was added dropwise to a solution of compound 44-e (6.0 g, 20 mmol) in anhydrous THF (100 mL). The mixture was slowly warmed to room temperature and further stirred for 20 mins, saturated NH.sub.4Cl aq. solution (30 mL) was added, the mixture was extracted with EA (30 mL?3). The organic phases were combined, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1-1:1) to give compound 44-d (4.8 g, yield 94%). LC-MS (ESI): m/z=256 [M+H].sup.+.

[0551] Synthesis of Compound 44-c

[0552] At 0 , triethyl phosphonoacetate (5.6 mL, 20 mmol) and sodium hydride (1.6 g, 20 mmol) were added to a solution of compound 44-d (4.8 g, 18.9 mmol) in THF (100 mL) respectively. The mixture was stirred for 1 h, warmed to room temperature, followed by adding NH.sub.4Cl aq. solution (100 mL), being extracted with EA (100 mL?3). The organic phases were combined, washed in turn with water (100 mL?3) and saturated brine (100 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give light yellow solid 44-c (5.2 g, yield 89%). LC-MS (ESI): m/z=326 [M+H].sup.+.

[0553] Synthesis of Compound 44-b

[0554] At 0? C., NaBH.sub.4 (0.38 g, 10 mmol) was added into a solution of compound 44-c (5.2 g, 16 mmol) and NiCl.sub.2 (1.3 g, 10 mmol) in methanol (50 mL). The mixture was stirred for 3 hrs, warmed to room temperature, followed by adding saturated NH.sub.4Cl aqueous solution (100 mL), being extracted with EA (10 mL?3). The organic phases were combined, washed in turn with water (50 mL?3) and saturated brine (50 mL), dried over anhydride sodium sulfate, filtered, and evaporated under reduced pressure. The residue was purified with silica column chromatography (PE:EA=4:1) to give light yellow solid 44-b (2.24 g, yield 43%). LC-MS (ESI): m/z=328 [M+H].sup.+.

[0555] Synthesis of Compound 44A-a and 44B-a

[0556] Under N.sub.2 atmosphere, compound 44-b (327 mg, 1 mmol), 4-cyanophenyl boronic acid (150 mg, 1 mmol) and sodium carbonate (212 mg, 2 mmol) were suspended in dioxane (8 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (60 mg, 0.1 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, and then cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was in turn washed with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give racemic compound, followed by separating by enantiomeric chromatographic column (process I, mobile phase: Hexane:EtOH:DEA=70:30:0.1), compound 44A-a (80 mg, yield 22.8%; LC-MS (ESI): m/z=351 [M+H].sup.+(T.sub.r=6.0 min) was diluted firstly and compound 44B-a (90 mg, yield 25.6%; LC-MS (ESI): m/z=351 [M+H].sup.+) (T.sub.r=7.0 min) was diluted later. Absolute configuration of 44A-a and 44B-a remains unknown.

[0557] Synthesis of Compound 44A

[0558] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 44A-a (70 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 44A (53 mg, yield 82%). LC-MS (ESI): m/z=323 [M+H].sup.+.

[0559] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.30 (s, 1H), 9.07 (s, 1H), 8.52 (s, 1H), 8.06 (d, J=8.0 Hz, 2H), 7.97 (d, J=8.0 Hz, 2H), 7.51 (s, 1H), 3.58 (m, 1H), 2.66 (t, J=8.0 Hz, 2H), 1.37 (d, J=8.0 Hz, 3H) ppm.

[0560] Synthesis of Compound 44B

[0561] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 44B-a (70 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 44B (39 mg, yield 60.6%). LC-MS (ESI): m/z=323 [M+H].sup.+.

[0562] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.30 (s, 1H), 9.07 (s, 1H), 8.52 (s, 1H), 8.06 (d, J=8.0 Hz, 2H), 7.97 (d, J=8.0 Hz, 2H), 7.51 (s, 1H), 3.58 (m, 1H), 2.66 (t, J=8.0 Hz, 2H), 1.37 (d, J=8.0 Hz, 3H) ppm.

Embodiment 45

[0563] ##STR00137##

[0564] Synthesis of Compound 45A-a and 45B-a

[0565] Under N.sub.2 atmosphere, compound 44-b (800 mg, 2.5 mmol), compound 3-c (750 mg, 2.5 mmol) and sodium carbonate (510 mg, 5 mmol) were suspended in dioxane (8 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (140 mg, 0.25 mmol) was added. The mixture was stirred for 3 hrs at 80? C., cooled to room temperature, filtered through celite, the filtrate cake was washed with EA (50 mL). The filtrate was washed in turn with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give racemic compound, followed by separating by enantiomeric chromatographic column (process II, mobile phase: CO.sub.2:Methanol (0.1% NH.sub.4OH)=65:35), compound 45A-a was diluted firstly (260 mg, yield 26%; LC-MS (ESI): m/z=401 [M+H].sup.+) (T.sub.r=8.5 min), and compound 45B-a (230 mg, yield 23%; LC-MS (ESI): m/z=401 [M+H].sup.+) (T.sub.r=10.5 min) was diluted later. Absolute configuration of 45A-a and 45B-a remains unknown.

[0566] Synthesis of Compound 45A

[0567] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 45A-a (80 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 45A (61 mg, yield 82%). [?].sup.25.sub.D=+26.248 (c=1.1018 MeOH), LC-MS (ESI): m/z=373 [M+H].sup.+.

[0568] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.27 (s, 1H), 9.17 (s, 1H), 8.43 (s, 1H), 8.33 (d, J=7.2 Hz, 1H), 8.27 (d, J=8.4 Hz, 1H), 7.90 (dd, J=7.2 Hz, 5.6 Hz, 1H), 7.83 (d, J=7.2 Hz, 1H), 7.68 (dd, J=6.8 Hz, 6.0 Hz, 1H), 7.64 (d, J=8.4 Hz, 1H), 7.52 (s, 1H), 3.50 (m, 1H), 2.60 (m, 2H), 1.31 (dd, J=7.6 Hz, 6.8 Hz, 3H) ppm.

[0569] Synthesis of Compound 45B

[0570] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 45B-a (80 mg, 0.2 mmol) in methanol (1 mL), THF (2 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (2 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 45B (56 mg, yield 75%). [?].sup.25.sub.D=?25.594 (c=1.002 MeOH), LC-MS (ESI): m/z=373 [M+H].sup.+.

[0571] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.27 (s, 1H), 9.17 (s, 1H), 8.43 (s, 1H), 8.33 (d, J=7.2 Hz, 1H), 8.27 (d, J=8.4 Hz, 1H), 7.90 (dd, J=7.2 Hz, 5.6 Hz, 1H), 7.83 (d, J=7.2 Hz, 1H), 7.68 (dd, J=6.8 Hz, 6.0 Hz, 1H), 7.64 (d, J=8.4 Hz, 1H), 7.52 (s, 1H), 3.50 (m, 1H), 2.60 (m, 2H), 1.31 (dd, J=7.6 Hz, 6.8 Hz, 3H) ppm.

Embodiment 46

[0572] ##STR00138## ##STR00139##

[0573] Synthesis of Compound 46-b

[0574] Under N.sub.2 atmosphere, at ?78? C., 2.5M n-butyl lithium in n-hexane (2.0 mL, 5 mmol) was slowly added to a solution of diisopropylamine (505 mg, 5 mmol) in anhydrous THF (10 mL) dropwise. The mixture was stirred for 15 mins, followed by adding a solution of compound 30-b (630 mg, 2 mmol) in anhydrous THF (10 mL) dropwise, the mixture was stirred for 2 hrs, followed by adding CH.sub.3I (720 mg, 5 mmol) and the mixture was further stirred for 3 hrs. The mixture was slowly warmed to room temperature, followed by adding saturated NH.sub.4Cl aq. solution (30 mL), being extracted with EA (30 mL?3). The organic phases were combined, washed in turn with water (10 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica preparative plate chromatography (PE:EA=2:1-1:1) to give compound 46-b (170 mg, yield 26%). LC-MS (ESI): m/z=328 [M+H].sup.+.

[0575] Synthesis of Compound 46A-a and 46B-a

[0576] Under N.sub.2 atmosphere, compound 46-b (170 mg, 0.52 mmol), compound 3-c (145 mg, 0.52 mmol) and sodium carbonate (120 mg, 1.13 mmol) were suspended in dioxane (4 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (43 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 3 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was filtered through celite, the filtrate cake was washed with EA (30 mL). The filtrate was washed in turn with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous magnesium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give racemic compound, followed by separating by enantiomeric chromatographic column (process I, mobile phase: Hexane:EtOH:DEA=80:20:0.1), compound 46A-a was eluted firstly (66 mg, yield 31%; LC-MS (ESI): m/z=401 [M+H].sup.+) (T.sub.r=14.0 min) and compound 46B-a was eluted later (61 mg, yield 29%; LC-MS (ESI): m/z=401 [M+H].sup.+) (T.sub.r=18.0 min). Absolute configuration of 46A-a and 46B-a remains unknown.

[0577] Synthesis of Compound 46A

[0578] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 46A-a (60 mg, 0.15 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (10 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 46A (26 mg, yield 46%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0579] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.31 (s, 1H), 9.17 (s, 1H), 8.44 (s, 1H), 8.33 (d, J=8.0 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.88 (m, 2H), 7.66 (m, 2H), 7.49 (s, 1H), 3.16 (m, 1H), 3.02 (m, 1H), 2.68 (m, 1H), 1.23 (d, J=6.8 Hz, 1H) ppm.

[0580] Synthesis of Compound 46B

[0581] At room temperature, LiOH (42 mg, 1 mmol) was added to a solution of compound 46B-a (60 mg, 0.15 mmol) in methanol (1 mL), THF (4 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution (1 mL) and water (10 mL), solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give compound 46B (26 mg, yield 46%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0582] .sup.1H-NMR (400 MHz, DMSO-d.sub.6) ?: 12.31 (s, 1H), 9.17 (s, 1H), 8.44 (s, 1H), 8.33 (d, J=8.0 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.88 (m, 2H), 7.66 (m, 2H), 7.49 (s, 1H), 3.16 (m, 1H), 3.02 (m, 1H), 2.68 (m, 1H), 1.23 (d, J=6.8 Hz, 1H) ppm.

Embodiment 47

3[4-(4-Cyanonaphthalen-1-yl)thieno[2,3-c]pyridin-2-yl]-2,2-dimethyl propionic acid (Compound 47)

[0583] ##STR00140##

[0584] Synthesis of Compound 47-d

[0585] At ?78? C., 1M Lithium diisopropylamide in THF (3 mL, 3 mmol) was slowly added to a solution of methyl isobutyrate (306 mg, 3 mmol) in anhydrous THF (4 mL). The mixture was stirred for 1 h, followed by adding compound 37-c (242 mg, 1 mmol), the mixture was further stirred for 1 h. The mixture was slowly warmed to room temperature, followed by adding saturated NaHCO.sub.3 aq. solution (20 mL), being extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give compound 47-d (425 mg). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=344 [M+H].sup.+.

[0586] Synthesis of Compound 47-c

[0587] Thionyl chloride (6 mL) was added to a solution of compound 47-d (425 mg) in DCM (10 mL). The mixture was heated to 40? C., stirred for 16 hrs and concentrated under reduced pressure to remove the solvent. Water (15 mL) was added to the residue, the mixture was extracted with EA (15 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give compound 47-c (487 mg). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=364 [M+H].sup.+.

[0588] Synthesis of Compound 47-b

[0589] At room temperature, NaBH.sub.4 (204 mg, 5.37 mmol) was added to a mixture of compound 47-c (487 mg), 10% PdC (50 mg) and ethanol (20 mL) in portions, the mixture was stirred for 16 hrs. The mixture was filtered through celite, the filtrate cake was washed with ethanol (10 mL?3). The filtrate was concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=5:1) to give compound 47-b (135 mg, yield 31%). LC-MS (ESI): m/z=328 [M+H].sup.+.

[0590] Synthesis of Compound 47-a

[0591] Under N.sub.2 atmosphere, compound 47-b (135 mg, 0.41 mmol), compound 3-c (121 mg, 0.43 mmol) and sodium sulfate (106 mg, 1 mmol) were suspended in dioxane (8 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (30 mg , 0.04 mmol) was added. The mixture was stirred at 90? C. for 16 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 47-a (130 mg, yield 79%). LC-MS (ESI): m/z=401 [M+H].sup.+.

[0592] Synthesis of Compound 47

[0593] At room temperature, LiOH (55 mg, 1.3 mmol) was added to a solution of compound 47-a (130 mg, 0.32 mmol) in methanol (1 mL), THF (5 mL) and water (1 mL). The mixture was stirred for 1 h, followed by adding 1M HCl aq. solution to adjust pH=5-6, being extracted with EA (15 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was prepared by HPLC (mobile phase: 10 mM NH.sub.4HCO.sub.3 aq. solution: acetonitrile=35%-45%) to give white solid 47 (13 mg, yield 10.5%). LC-MS (ESI): m/z=387 [M+H].sup.+.

[0594] 1H-NMR (400 MHz, CD.sub.3OD) ?: 9.22 (s, 1H), 8.39 (s, 1H), 8.22 (d, J=8.1 Hz, 1H), 8.10-8.01 (m, 1H), 7.71 (dd, J=7.9 Hz, 3.7 Hz, 1H), 7.60 (d, J=7.1 Hz, 1H), 7.50 (s, 2H), 6.68 (s, 1H), 3.13-3.02 (m, 2H), 1.19 (s, 3H), 1.18 (s, 3H) ppm.

Embodiment 48

3-[4-(4-Cyanophenyl)thieno[2,3-c]pyridin-2-yl]-2,2-dimethyl propionic acid (Compound 48)

[0595] ##STR00141##

[0596] Synthesis of Compound 48-c

[0597] Thionyl chloride (5 mL) was added to a solution of compound 37-d (200 mg, 0.82 mmol) in DCM (10 mL). The mixture was heated to 30? C., stirred for 16 hrs, and concentrated under reduced pressure to give compound 48-c (236 mg). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=264 [M+H].sup.+.

[0598] Synthesis of Compound 48-b

[0599] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (1.37 mL, 3.43 mmol) was slowly added to a solution of diisopropylamine (347 mg, 3.43 mmol) in anhydrous THF (10 mL). The mixture was warmed to 0? C. and further stirred for 1 h, then cooled again to -78? C., methyl isobutyrate (350 mg, 3.43 mmol) was added, the mixture was stirred for 1 h, followed by adding compound 48-c (180 mg, 0.69 mmol) and further stirred for 1 h. The mixture was slowly warmed to room temperature, stirred for 2 hrs, followed by adding saturated NH.sub.4Cl aq. solution (20 mL), being extracted with EA (50 mL?2). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 48-b (280 mg, yield 97%). LC-MS (ESI): m/z=329 [M+H].sup.+.

[0600] Synthesis of Compound 48-a

[0601] Under N.sub.2 atmosphere, compound 48-b (280 mg, 0.85 mmol), 4-cyanophenylboronic acid (138 mg, 0.94 mmol) and sodium sulfate (180 mg, 1.7 mmol) were suspended in dioxane (15 mL) and water (2 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (62 mg, 0.08 mmol) was added. The mixture was added at 90? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 48-a (135 mg, yield 45%). LC-MS (ESI): m/z=351 [M+H].sup.+.

[0602] Synthesis of Compound 48

[0603] At room temperature, LiOH (65 mg, 1.54 mmol) was added to a solution of compound 48-a (135 mg, 0.38 mmol) in methanol (1 mL), THF (5 mL) and water (1 mL). The mixture was stirred for 6 hrs, 1M HCl aq. solution was added to adjust pH=5-6, and concentrated under reduced pressure. The residue was adjusted to pH=7-8 with 2M NaOH aq. solution, and then extracted with EA (10 mL) to remove the impurities. The aqueous phase was adjusted to pH=5-6 with 1M HCl aq. solution, extracted with EA (15 mL?2). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give yellow solid 48 (75 mg, yield 58%). LC-MS (ESI): m/z=337 [M+H].sup.+.

[0604] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.52 (s, 1H), 9.21 (s, 1H), 8.48 (s, 1H), 8.03 (d, J=8.2 Hz, 2H), 7.84 (d, J=8.2 Hz, 2H), 7.30 (s, 1H), 3.21 (s, 2H), 1.16 (s, 6H) ppm.

Embodiment 49

2-[4-(4-Cyanonaphthalen-1-yl)isoquinolin-6-yl]-2-methyl propionic acid (Compound 49)

[0605] Synthetic Route

##STR00142##

[0606] Synthesis of Compound 49-a

[0607] Under N.sub.2 atmosphere, trimethylchlorosilane (11 mg, 0.1 mmol) was added dropwise to a solution of Zn powder (130 mg, 2 mmol) and THF (4 mL). The mixture was stirred for 15 mins at room temperature, heated to 40? C., followed by adding a solution of methyl 2-bromoisobutyrate (181 mg, 1 mmol) in THF (2 mL). The mixture was further stirred at 40? C. for 30 mins, added to a mixture of compound 5-b (90 mg, 0.25 mmol), LiCl (11 mg, 0.25 mmol), tris(dibenzylidene indene acetone)dipalladium (23 mg, 0.025 mmol), 2-dicyclohexylphospho-2,6-diisopropoxy-1,1-biphenyl (12 mg, 0.025 mmol) and THF (4 mL). The mixture was heated to 80? C. and further stirred for 1 h, and then cooled to room temperature, and concentrated under reduced pressure to remove the solvent. The residue was dissolved in DCM (50 mL), washed in turn with water (20 mL?3) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure. The residue was purified by silica preparative plate chromatography (DCM: methanol=20:1) to give compound 49-a (40 mg, yield 42%). LC-MS (ESI): m/z=381 [M+H].sup.+.

[0608] Synthesis of Compound 49

[0609] At room temperature, LiOH (22 mg, 0.5 mmol) was added to a solution of compound 49-a (40 mg, 0.1 mmol) in methanol (1 mL) and THF (3 mL). The mixture was stirred for 16 hrs, evaporated to remove the solvent, followed by adding water (5 mL), being extracted with EA (10 mL?3). 1M HCl aq. solution was added to the aqueous phase to adjust pH=5-6, extracted with EA (15 mL?3), the organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was prepared by HPLC (mobile phase: water (0.05% trifluoroacetic acid): nitrile=25%-40%) to give compound 49 (15 mg, yield 39%). LC-MS (ESI): m/z=367 [M+H].sup.+.

[0610] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 9.39 (s, 1H), 8.50 (s, 1H), 8.36 (d, J=8.4 Hz, 1H), 8.13 (d, J=8.4 Hz, 1H), 7.77 (d, J=8.4 Hz, 1H), 7.72-7.67 (m, 1H), 7.58 (d, J=7.2 Hz, 1H), 7.48-7.46 (m, 2H), 7.34 (s, 1H), 1.45 (s, 6H) ppm.

Embodiment 50

2-{[4-(4-Cyanonaphthalen-1-yl)phthalazin-6-yl]thio}-2-methyl propionic acid (Compound 50)

[0611] Synthetic Route

##STR00143## ##STR00144##

[0612] Synthesis of Compound 50-f

[0613] 6-Bromo-phthalide (2.30 g, 10.9 mmol) was added to a solution of N-bromosuccinimide (2.1 g, 11.8 mmol), azobisisobutyronitrile (0.1 g, 0.06 mmol) in 1,2-dichloroethane (60 mL). The mixture was heated to reflux for 2 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was washed with water (10 mL?3) to give compound 50-f. The product was used directly for the next step without further purification.

[0614] Synthesis of Compound 50-e

[0615] A mixture of compound 50-f and water (40 mL) was heated to reflux for 2 hrs, cooled to room temperature, white solid was precipitated and filtered out. Solid was washed with water (20 mL?3), dried under vacuum to give compound 50-e (1.6 g, yield 64%). The product was used directly for the next step without further purification.

[0616] Synthesis of Compound 50-d

[0617] 85% Hydrazine hydrate (2 mL) was added to a solution of compound 50-e (1.60 g, 7 mmol) in isopropyl alcohol (40 mL). The mixture was heated to reflux for 2 hrs, cooled to room temperature, white solid was precipitated and filtered out. The solid was washed with water (20 mL?3), dried under vacuum to give compound 50-d (1.2 g, yield 76%). The product was used directly for the next step without further purification.

[0618] Synthesis of Compound 50-c

[0619] A mixture of compound 50-d (600 mg, 2.67 mmol) and POCl.sub.3 (8 mL) was heated to reflux for 1.5 h, cooled to room temperature and concentrated under reduced pressure. The residue was dissolved in DCM (40 mL), washed in turn with saturated sodium bicarbonate (40 mL) and saturated brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 50-c (500 mg, yield 75%). LC-MS (ESI): m/z=243 [M+H].sup.+.

[0620] Synthesis of Compound 50-b

[0621] Under N.sub.2 atmosphere, tris(dibenzylidene indene acetone)dipalladium (30 mg, 0.03 mmol) and 4,5-bis(diphenylphosphine)-9,9-dimethyloxacanthracene (38 mg, 0.06 mmol) were added to a solution of compound 50-c (131 mg, 0.5 mmol), ethyl 2-methyl-2-mercaptopropionate (73 mg, 0.5 mmol) and diisopropylethylamine (193 mg, 1.5 mmol) in dioxane (10 mL). The mixture was stirred at 100? C. for 16 hrs, cooled to room temperature, concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give compound 50-b (120 mg, yield 77%). LC-MS (ESI): m/z=311 [M+H].sup.+.

[0622] Synthesis of Compound 50-a

[0623] Under N.sub.2 atmosphere, compound 50-b (120 mg, 0.38 mmol), compound 3-c (111 mg, 0. 4 mmol) and sodium carbonate (170 mg, 2.8 mmol) were suspended in ethylene glycol dimethyl ether (10 mL) and water (1 mL), [1,1-bis(diphenylphosphine)ferrocene]palladium dichloride (43 mg, 0.05 mmol) was added. The mixture was stirred at 80? C. for 4 hrs, cooled to room temperature and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=2:1) to give compound 50-a (96 mg, yield 60%). LC-MS (ESI): m/z=428 [M+H].sup.+.

[0624] Synthesis of Compound 50

[0625] At room temperature, 1M LiOH aq. solution (3.0 mL) was added to a solution of compound 50-a (86 mg, 0.2 mmol) in methanol (4 mL) and THF (8 mL). The mixture was stirred for 16 hrs and concentrated under reduced pressure. The residue was dissolved in water (10 mL), adjusted to pH=3 with 1M HCl aq. solution, solid was precipitated and filtered out. The solid was washed with water (5 mL), dried under vacuum to give white solid 50 (60 mg, yield 75%). LC-MS (ESI): m/z=400 [M+H].sup.+.

[0626] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.77 (s, br. 1H,), 9.87 (s, 1H), 8.39 (d, J=8.0 Hz, 1H), 8.30 (d, J=8.0 Hz, 2H), 7.98-8.00 (m, 1H), 7.85-7.90 (m, 2H), 7.62 (t, J=8.0 Hz, 1H), 7.47 (d, J=8.8 Hz, 1H), 7.42 (s, 1H), 1.32 (s, 3H), 1.26 (s, 3H) ppm.

Embodiment 51

3-[4-(4-Cyanophenyl)isoquinolin-6-yl]-2,2-dimethyl propionic acid (Compound 51)

[0627] Synthetic Route

##STR00145##

[0628] Synthesis of Compound 51-d

[0629] At 0? C., lithium aluminum hydride (214 mg, 5.64 mmol) was suspended in anhydrous THF (100 mL), a solution of compound 19-f (1.5 g, 5.64 mmol) in THF (10 mL) was slowly added. The mixture was stirred for 10 mins, Na.sub.2SO.sub.4.10H.sub.2O (2.0 g) was added in portions, then the mixture was warmed to room temperature and further stirred for 30 mins. The mixture was filtered, the filtrate cake was washed with EA (20 mL). The filtrate was concentrated under reduced pressure, the residue was purified by silica column chromatography (PE:EA=3:1) to give compound 51-d (600 mg, yield 44%). LC-MS (ESI): m/z=238 [M+H].sup.+.

[0630] Synthesis of Compound 51-c

[0631] Thionyl chloride (1.84 mL) was added to a solution of compound 51-d (600 mg, 2.52 mmol) in DCM (25 mL). The mixture was heated to 30? C., stirred for 16 hrs and concentrated under reduced pressure to give compound 51-c (720 mg). The product was used directly for the next step without further purification. LC-MS (ESI): m/z=256 [M+H].sup.+.

[0632] Synthesis of Compound 51-b

[0633] Under N.sub.2 atmosphere, at ?78? C., a solution of 2.5M n-butyl lithium in n-hexane (2.05 mL, 5.1 mmol) was added to a solution of diisopropylamine (0.72 mL, 5.1 mmol) in anhydrous THF (20 mL). The mixture was warmed to room temperature, stirred for 1 h, cooled again to ?78? C. The mixture was added to methyl isobutyrate (0.59 mL, 5.1 mmol), stirred for 1 h, followed by adding compound 51-c (300 mg, 1.02 mmol) and further stirred for 1 h. The mixture was slowly warmed to room temperature, stirred for 2 hrs, followed by adding saturated NH.sub.4Cl aq. solution (20 mL), being extracted with EA (50 mL?2). The organic phases were combined, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1) to give yellow oil 51-b (300 mg, yield 91%). LC-MS (ESI): m/z=322 [M+H].sup.+.

[0634] Synthesis of Compound 51-a

[0635] Under N.sub.2 atmosphere, compound 51-b (300 mg, 0.93 mmol), 4-cyanophenylboronic acid (215 mg, 0.93 mmol) and sodium carbonate (296 mg, 2.79 mmol) were suspended in DMF (10 mL) and water (5 mL), [1,1-bis(diphenylphosphine)ferrocene] palladium dichloride (76 mg, 0.09 mmol) was added. The mixture was stirred at 80? C. for 16 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=3:1-2:1) to give compound 51-a (250 mg, yield 78%). LC-MS (ESI): m/z=345 [M+H].sup.+.

[0636] Synthesis of Compound 51

[0637] At room temperature, LiOH (152 mg, 3.6 mmol) was added to a solution of compound 51-a (250 mg, 0.72 mmol) in methanol (1 mL), THF (5 mL) and water (2 mL). The mixture was stirred for 6 hrs, 1M HCl aq. solution was added to adjust pH=5-6, the mixture was concentrated under reduced pressure, extracted with EA (20 mL?3). The organic phases were combined, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was prepared by HPLC (mobile phase: water (0.01% NH.sub.3+10 mm NH.sub.4HCO.sub.3):nitrile=45%-75%) to give compound 51 (33 mg, yield 14%). LC-MS (ESI): m/z=331 [M+H].sup.+.

[0638] .sup.1H-NMR (400 MHz, CDCl.sub.3) ?: 9.19 (s, 1H), 8.36 (s, 1H), 7.94 (m, 1H), 7.51-7.65 (m, 6H), 3.06 (s, 2H), 1.27 (s, 6H) ppm.

Embodiment 52

3-[7-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridine-2-yl]-butyric acid (Compound 52)

[0639] Synthetic Route

##STR00146##

[0640] Synthesis of Compound 52-b

[0641] Under N.sub.2 atmosphere, compound 44-c (9.0 g, 27.6 mmol), compound 3-c (15.4 g, 55.2 mmol) and sodium carbonate (5.85 g, 55.2 mmol) were suspended in dioxane (240 mL) and water (40 mL), [1,1-bis(diphenylphosphine)ferrocene] palladium dichloride (1.0 g, 1.38 mmol) was added. The mixture was stirred at 80? C. for 16 hrs, cooled to room temperature, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=10:1) to give yellow solid 52-b (9.1 g, yield 82.8%). LC-MS (ESI): m/z=399 [M+H].sup.+.

[0642] Synthesis of Compound 52-a

[0643] Under H.sub.2 (1 atm.) atmosphere, palladium hydroxide (3.0 g) was added to a solution of compound 52-b (9.1 g, 22.8 mmol) in THF (100 mL) and methanol (280 mL). The mixture was stirred for 16 hrs, filtered, and concentrated under reduced pressure. The residue was purified by silica column chromatography (PE:EA=1:1) to give yellow oil 52-a (8.0 g, yield 87.5%). LC-MS (ESI): m/z=401 [M+H].sup.+.

[0644] Synthesis of Compound 52

[0645] At room temperature, LiOH (1.51 g, 36 mmol) was added to a solution of compound 52-a (8.0 g, 20 mmol) in methanol (15 mL), THF (30 mL) and water (5 mL). The mixture was stirred for 8 hrs, followed by adding 1M HCl aq. solution to adjust pH=5-6, solid was precipitated and filtered out. The solid was washed with water (20 mL?3), dried under vacuum to give white solid 52 (6.18 g, yield 83%). LC-MS (ESI): m/z=373 [M+H].sup.+.

[0646] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.27 (s, 1H), 9.17 (s, 1H), 8.43 (s, 1H), 8.33 (d, J=7.2 Hz, 1H), 8.27 (d, J=8.4 Hz, 1H), 7.90 (dd, J=7.2 Hz, 5.6 Hz, 1H), 7.83 (d, J=7.2 Hz, 1H), 7.68 (dd, J=6.8 Hz, 6.0 Hz, 1H), 7.64 (d, J=8.4 Hz, 1H), 7.52 (s, 1H), 3.50 (m, 1H), 2.60 (m, 2H), 1.31 (dd, J=7.6 Hz, 6.8 Hz, 3H) ppm.

Embodiment 53

[0647] Compound 53A

[0648] Synthetic Route

##STR00147##

[0649] Synthesis of Compound 53A

[0650] At room temperature, NaOH (8 mg, 0.02 mmol) was added to a solution of compound 45A (74 mg, 0.02 mmol) in water (1 mL). The mixture was stirred for 2 hrs, freeze-dried to give white solid 53A (79 mg, yield 100%). LC-MS (ESI): m/z=373 [M?Na+2H].sup.+.

[0651] .sup.1H-NMR (400 MHz, DMSO-d6) ?: 9.11 (s, 1H), 8.38 (s, 1H), 8.32 (d, J=7.2 Hz, 1H), 8.27 (d, J=8.0 Hz, 1H), 7.88 (t, J=6.4 Hz, 1H), 7.82 (d, J=7.2 Hz, 1H), 7.65 (m, 2H), 7.42 (s, 1H), 3.47 (m, 1H), 2.23 (m, 1H), 2.11 (m, 1H), 1.25 (dd, J=7.2 Hz, 6.8 Hz, 3H) ppm.

Embodiment 54

3-[4-(4-Cyanonaphthalen-1-yl)thieno[3,2-c]pyridine-2-yl]-2,2-bis(triadecylmethyl) propionic acid (Compound 54)

[0652] ##STR00148##

[0653] Synthesis of Compound 54-b

[0654] According to the process for preparing compound 48-b, compound 54-b (1000 mg, 46%) was prepared by using commercially available compound 54-c. LC-MS (ESI): m/z=349 [M+H].sup.+.

[0655] According to the process for preparing compound 47-a, compound 54-a (500 mg, 72%) was prepared by using compound 54-b. LC-MS (ESI): m/z=421 [M+H].sup.+.

[0656] Synthesis of Compound 54

[0657] According to the process for preparing compound 47, white solid compound 54 (63 mg, 32%) was prepared by compound 47-a. LC-MS (ESI): m/z=394 [M+H].sup.+. .sup.1H-NMR (400 MHz, DMSO-d6) ?: 12.46(s, 1H), 9.30 (s, 1H), 8.45(s, 1H), 8.32(d, J=8Hz, 1H), 8.26(d, J=8Hz, 1H), 7.89(d, J=8Hz, 1H), 7.74(d, J=8Hz, 1H) , 7.65 (m, 1H) , 7.59 (m, 1H), 6.67(s, 1H), 3.09(s, 2H) ppm

EFFECT EXAMPLE

Biological Assessment

Example 1

The Inhibitory Activity Against URAT1 of the Compound of the Present Invention

[0658] Human embryonic kidney cells (HEK293) was incubated in DMEM tissue culture medium, at 37? C., under 5% CO.sub.2 and 95% air atmosphere. TransIT-293 transfection agent (MIRUS BIO, Cat. No. MIR2706) and model URAT1 were used to construct transfected HEK293 cells. Transfected HEK293/hURAT1 cells were used to the test for .sup.14C-uric acid transport activity.

[0659] HEK293/hURAT1 cells were seeded in a 96-well plate (BD, Cat. No. 356461) fully coating with poly-D-lysine at a density of 6?10.sup.4 cells per well. Cells were incubated at 37? C. for at least 12 hrs in the calorstat, and then washed with pre-heated washing buffer (125 mM sodium gluconate, 10 mM HEPES pH=7.4) at an amount of 200 pL per well to wash out the culture medium. The uric acid [8-14C] (ARC, Cat. No. ARC0513-250UCI) containing or not containing the compound was added to 50 ?L HBSS buffer which was free of chloric ion each well (HBSS buffer: 125 mM sodium gluconate, 4.8 mM potassium gluconate, 1.3 mM calcium gluconate, 1.2 mM potassium dihydrogen phosphate, 1.2 mM magnesium sulfate, 5.6 mM glucose, 25 mM HEPES pH=7.4) to make the specific concentration of the uric acid 1 ?Ci per well. The incubating solution was removed after 10 mins incubation, followed by adding 100 ?L cold washing buffer, after washing with this buffer for 3 times, the buffer was completely removed from the well. 50 ?L Lysis buffer (0.1 mM NaOH) was added to each well, and transferred to a 96-well plate (PERKIN ELMER, Cat. No. 6005040) containing scintillation fluid after 5 mins, and counted by MicroBeta Trilux (PerkinElmer) to give IC.sub.50 value eventually.

[0660] The inhibitory activity of the compound of the present invention against hURAT1 was tested according to the assessment above, the results were listed below (Table 1):

TABLE-US-00001 TABLE 1 IC.sub.50 value of partial compounds of the present invention against hURAT1 Compound IC.sub.50 (?M) Verinurad (RDEA3170) 0.113 1 2.534 2 0.161 3 0.327 4 0.015 5 0.008 6 0.214 7A 5.524 7B 2.687 8 0.057 9 0.127 10 0.019 11 0.062 12 0.071 13 0.189 14 0.385 15 0.024 16 0.015 17 0.012 21 0.100 22 0.055 23 0.018 24 0.018 25 0.289 26 0.119 27 1.731 29 2.858 30 0.087 31 3.418 32 5.405 33 0.042 34 0.139 35 2.408 36 0.542 37 0.035 38 0.209 40 3.467 41 0.934 42 0.024 43A 0.011 43B 0.037 44A 0.038 44B 1.858 45A 0.580 45B 0.010 46A 0.148 46B 0.051 47 0.018 48 0.012 49 0.116 50 0.971 51 0.019 52 0.037 / /

[0661] Compound Verinurad (RDEA3170, CAS No.:1352792-74-5) was a known hURAT1 inhibitor having a structure shown as below:

##STR00149##

[0662] What can be concluded from Table 1 was that compounds of the present invention are of significantly inhibitory effects against hURAT1.

[0663] It is to be understood that the foregoing description of two preferred embodiments is intended to be purely illustrative of the principles of the invention, rather than exhaustive thereof, and that changes and variations will be apparent to those skilled in the art, and that the present invention is not intended to be limited other than expressly set forth in the following claims.